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Abstract 
Bacterial cells often form sessile biofilms that are up to 1,000 times more resistant to 
antimicrobial agents than free-living cells. Meanwhile, bacteria produce a small subpopulation of 
slow-growing or non-growing persister cells that exhibit high tolerance to antibiotics. Both 
biofilms and persister cells play important roles in the recalcitrance of chronic infections. Recent 
studies have shown that bacterial cell-to-cell communication, named quorum sensing (QS), is 
involved in the biofilm and persister formation. 
In this study, we investigated the effects of quorum sensing signals N-(3-oxododecanoyl)-
homoserine lactone (3-oxo-C12-HSL) and N-butyryl homoserine lactone (C4-HSL) on isolated 
Pseudomonas aeruginosa PAO1 and PDO300 persister cells. Interestingly, 3-oxo-C12-HSL was 
found to increase antibiotic susceptibility of isolated P. aeruginosa PAO1 and PDO300 persister 
cells to ciprofloxacin in a dose-dependent manner, although such synergistic effect was not 
observed with ofloxacin, tobramycin, tetracycline, carbenicillin, and gentamicin. In contrast, C4-
HSL did not affect the susceptibility of P. aeruginosa PAO1 and PDO300 persister cells to 
ciprofloxacin. 
Additionally, we engineered polydimethylsiloxane (PDMS) surfaces by supplementing with (Z)-
4-bromo-5-(bromomethylene)-3-methylfuran-25(H)-one (BF8) to reduce P. aeruginosa PAO1 
biofilm formation and biofilm-associated persister cells. Compared with the PDMS surface
    
 
without BF8, P. aeruginosa PAO1 biofilm formation and biofilm-associated persister cells were 
significantly reduced on the PDMS surfaces containing BF8. For example, after 24 h, the number 
of biofilm cells and biofilm-associated persisters was inhibited by 98% ± 0.4% and 99% ± 0.5% 
on the PDMS surface containing 1800 μg/mL BF8, respectively. These results further support 
that bacterial cell-to-cell signaling is a possible target for controlling biofilm formation and 
persistence. 
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1.1 Acquired antibiotic resistance 
Since the discovery of penicillin in 1928 [1], antibiotics have been widely used for the treatment 
of numerous bacterial infections such as those associated with tuberculosis and cystic fibrosis. 
Antimicrobial agents can be classified into two types: bactericidal drugs that kill bacteria, and 
bacteriostatic drugs that inhibit growth of bacteria [2, 3]. There are three major classes of 
bactericidal antibiotics, for instance, fluoroquinolones that inhibit the ligation of DNA gyrase 
and topoisomerase, aminoglycosides that obstruct protein synthesis, and β-lactams that interfere 
with peptidoglycan synthesis [4-6]. Although these bactericidal antibiotics attack different targets, 
they all cause bacterial cell death by producing hydroxyl radicals that are capable of damaging 
DNA, lipids, and proteins [2, 7, 8].  
However, due to the overuse or incorrect usage of antibiotics, antibiotic resistant bacterial 
infections have become very pressing public health problems throughout the world [4, 6, 9]. 
According to the U.S. Centers for Disease Control and Prevention (CDC), more than 2 million 
Americans suffer from antibiotic resistant infections per year [10] leading to more than $20 billion 
per year in excess health care costs and up to $35 billion per year in societal costs [11]. Bacteria 
can acquire antibiotic resistance in different ways such as chromosomal mutation and horizontal 
gene transfer [4, 12, 13].  
The mechanisms of acquired bacterial multidrug resistance have been extensively studied 
including alteration of the antibiotic target site, prevention of drug access to bacterial targets, 
decreased permeability to antibiotics, enzymatic inactivation of antibiotics, and drug extrusion 
by efflux pumps [1, 4, 13]. The prevalence of antibiotic resistance has been found in many bacteria 
such as methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, 
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Mycobacterium tuberculosis, and Pseudomonas aeruginosa [14]. MRSA is resistant to all β-
lactams such as penicillin, carbepenem, and cephalosporin [13]. This is due to the mecA gene that 
encodes a new penicillin binding protein (PBP), which has a low affinity to β-lactams [13]. 
Vancomycin is still an effective antimicrobial agent to treat MRSA [12, 15, 16]. However, the 
elevated usage of this agent has caused other species, e.g. Enterococci, to be vancomycin-
resistant [13]. P. aeruginosa is a common Gram-negative pathogen that causes infections in 
patients with cystic fibrosis and compromised immune systems. Multidrug resistance of P. 
aeruginosa was attributed to overexpression of multidrug efflux pumps, genetic mutations, or 
horizontal gene transfer of antibiotic resistance genes [17-19]. 
1.2 Intrinsic antibiotic resistance 
In contrast to acquired antibiotic resistance, bacteria can also tolerate antibiotics through 
mechanisms that are not specific to certain classes of antimicrobials.  
1.2.1 Biofilms 
Biofilms are highly-structured microbial communities attached to surfaces and enclosed in a 
matrix of extracellular polymeric substance (EPS) [20]. EPS generally contains polysaccharides, 
proteins, and extracellular DNA [20, 21]. The presence of EPS allows the biofilms to contain open 
water channels for transport of nutrients into the biofilm and waste products out of the biofilm 
[20]. It has been well documented that bacteria in the biofilm are up to 1,000 times more resistant 
to antimicrobial agents than planktonic cells [22]. According to the National Institute of Health, 
more than 60% of nosocomial infections are associated with biofilms [12, 22-24].  
   4 
 
A well characterized model organism for biofilm study is P. aeruginosa that causes lung 
infection in cystic fibrosis patients. The development of P. aeruginosa biofilms occurs in the 
following five stages: 1) initial and reversible attachment of free-floating cells to the surface; 2) 
irreversible attachment; 3) production of the EPS matrix and early development of biofilm 
architecture; 4) maturation of biofilm architecture; 5) dispersion [20, 25]. Extracellular DNA 
(eDNA) has been found important to the initial attachment of P. aeruginosa biofilms [21]. 
Additionally, one finding suggested that eDNA is similar to chromosomal DNA based on the 
polymerase chain reaction (PCR) and Southern analysis results [26].    
A number of studies have been reported in attempt to understand the genetic basis of biofilm 
formation. Whiteley et al. [25] found that 73 genes are differentially expressed in P. aeruginosa 
biofilm cells compared with free-living cells based on DNA microarray results. Among them, 34 
genes were upregulated while 39 genes were downregulated. Interestingly, seven genes coding 
for flagella and pili were repressed in mature biofilm populations, which means that flagella and 
pili may not be necessary for mature biofilm development [25]. In addition, the rpoS gene that 
encodes an RNA polymerase σ subunit was also repressed in the microarray data [25]. Within 4 h, 
the isogenic rpoS mutant of P. aeruginosa produced 2-fold more biofilm biomass than the wild-
type strain [25]. In addition, biofilms of the rpoS mutant were much more resistant to tobramycin 
compared to wild-type P. aeruginosa biofilms [25]. These results show that the rpoS gene plays 
important roles in biofilm formation and tobramycin susceptibility [25].  
It is speculated that biofilm-associated drug resistance is due to low growth of biofilm [27], drug 
efflux [28], and impaired diffusion of drugs into cells due to the matrix material [29-31]. However, 
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Lewis et al. [32] found that the majority of cells in the biofilm can be killed by antibiotics except 
for a small subpopulation, known as persister cells. 
1.2.2 Persister cells 
In 1944, J. W. Bigger defined persister cells when he studied incomplete killing of Staphylococci 
by penicillin [33]. He found that these dormant persister cells make up only a small fraction of the 
bacterial population, which neither grow nor die in the presence of antibiotics. When persister 
cells are inoculated into a fresh medium, they can revert to normal cells and be killed by 
antibiotics. Thus, persister cells are not antibiotic-resistant mutants but rather phenotypic variants, 
which may play important roles in chronic infections [5]. E. coli, P. aeruginosa, and M. 
tuberculosis are well characterized for their persister formation, and it is speculated that virtually 
any bacterial culture may contain persister cells [34-37].  
1.2.2.1 Formation of persister cells 
Persister formation increases in biofilms and stationary phase cultures [5, 38]; biofilms of E. coli 
and P. aeruginosa contain 0.1%-1% cells as persister cells. The mechanisms of persister 
formation are still poorly understood. No negative mutants of persister formation were found 
after screening the transposon insertion libraries of E. coli [39, 40] and P. aeruginosa PAO1 [41], 
suggesting the redundancy in persister genes. However, a number of factors have been linked to 
persister formation [42]. 
1) Persisters and heterogeneous growth 
   6 
 
The finding that persister cells only make up a small percentage of the population suggests the 
heterogeneity in growth rates of a given bacterial population [43-45]. Actively growing bacterial 
cells are more susceptible to antibiotics than non-growing and dormant cells. In 2004, Balaban et 
al. [43] studied the persistence of individual bacterial cells of E. coli high persistence (hip) 
mutants using transparent microfluidic devices. The results indicate persistence is associated 
with preexisting heterogeneity in bacterial populations due to the phenotypic switch between 
actively growing cells and persister cells with reduced growth rates [43]. 
2) Persisters and SOS response 
SOS response is a global response system in bacteria, in which DNA replication and cell division 
are arrested and DNA repair is induced [46]. More than 40 genes are involved in SOS response 
including the genes recA and lexA [46, 47]. SOS response was proposed to induce several TA 
systems containing tisAB/istR, symER, yafN/yafO, and hokE [48-50]. The connection between SOS 
response and persistence has been studied in recent years. One finding showed that the 
fluoroquinolone antibiotic ciprofloxacin (Cip), which targets gyrase and topoisomerase and 
results in double-strand breaks, induced the persister formation in E. coli by activation of SOS 
response [47]. Additionally, another independent study suggested that the TisB toxin controlled 
the persister formation induced by Cip in E. coli [36]. The TisB toxin is a membrane-acting 
peptide that disrupts the proton motive force (pmf) and results in reduced ATP levels [36]. As a 
result, the TisB toxin induced dormancy and multidrug tolerance in E. coli by the shutdown of 
antibiotic targets [36].   
3) Persisters and toxin/antitoxin modules 
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Toxin/antitoxin (TA) modules are ubiquitous and have been found on the chromosomes and 
plasmids of bacteria [51]. TA systems have been extensively studied for their roles in plasmid 
maintenance [51]. However, the role of chromosomally encoded TA systems remains unclear [52]. 
Typically, a TA module is composed of two genes in an operon which encodes a stable protein 
toxin that interrupts important cellular functions and a labile antitoxin degraded by a specific 
protease such as Lon, ClpAP, and ClpXP [53]. To date, gyrase and mRNA have been found as 
two major targets of TA toxins [54]. Antitoxins are small RNAs in type I (that inhibit toxin 
translation) and type III (that inhibit toxin activity) TA modules or proteins in type II (that inhibit 
toxin activity) TA modules [55]. Antitoxin can bind to its cognate toxin and then form a stable and 
non-toxic complex which functions as a repressor of the TA operon [54].  
Recent work suggests that TA modules are involved in persister formation [53, 55, 56]. Based on 
biochemical and bioinformatics analyses, at least 36 putative TA modules have been identified in 
E. coli K-12 [57]. Among them, eight TA modules have been well studied including hipBA, relBE, 
mazEF, chpBIK, yafNO, mqsAR, yefM-yoeB, and dinJ-yafQ [57]. It suggested that more persister 
cells are formed when toxins such as HipA and RelE are overexpressed [36, 53, 58]. However, due 
to the redundancy in TA modules, only a few TA systems cause a sharp reduction in persistence 
when their toxin genes are deleted [36, 53]. The hipA (high persistence) gene, located in the hipBA 
operon, was the first recognized persistence gene in E. coli K-12. It encodes a 440-amino-acid 
inhibitor of cell growth [59]. Compared to the wild-type strain, the hipA mutant exhibited a 1,000-
fold increase in the level of persister cells [60].  
In M. tuberculosis, more than 60 putative TA modules have been identified including relBE and 
mazEF [57]. For P. aeruginosa PAO1, only three TA loci have been described to date including 
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higBA, relBE, and parDE [51, 61]. Williams et al. [51] showed that higBA and relBE TA systems 
were present and transcribed in clininal isolates of P. aeruginosa.    
1.2.2.2 Current methods of persister control  
Due to the high level antibiotic tolerance of persister cells, it is important to develop new 
antimicrobials for persister control. However, eradicating persister cells remains challenging. 
Allison et al. [62] suggested that specific metabolites such as mannitol, glucose and fructose could 
potentiate the killing of E. coli and S. aureus persister cells by aminoglycosides. This approach 
depends on the generation of proton motive force by these sugars which enhance the uptake of 
aminoglycosides. This study showed that metabolic activities can be a good target for persister 
control.  
Using a different approach, Conlon et al. [63] found that a compound (acyldepsipeptide antibiotic, 
ADEP4) can eradicate actively growing, stationary and biofilm populations of S. aureus in 
combination with rifampicin. ADEP4 activates and dysregulates caseinolytic protease P (ClpP) 
that is characterized as the proteolytic core of bacterial protein degradation machinery in an 
ATP-dependent process [64]. Interestingly, ADEP4-activated ClpP enables the degradation of 
over 400 proteins in the absence of ATP [63, 65]. The cell division protein FtsZ was proposed to be 
a major target of ADEP4-activated ClpP [66]. Thus, ADEP4 primarily inhibits bacterial cell 
division and eventually causes cell death.  
In addition, 3-[4-(4-methoxyphenyl)piperazin-1-yl]piperidin-4-yl biphenyl-4-carboxylate (C10), 
has been reported to reduce E. coli and P. aeruginosa persister formation in combination with 
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fluoroquinolone antibiotics [67]. C10 appeared to revert persister cells to antibiotic-susceptible 
cells at growth non-inhibitory concentrations. 
Recent work has suggested that bactericidal antibiotics promote the generation of reactive 
oxygen species (ROS) and thus result in bacterial cell death [7]. As reported by Grant et al. [7], 
decrease in dissolved oxygen (DO) of bacterial media facilitated the persister survival. On the 
contrary, all cells could be killed by antibiotics via sufficient ROS if DO concentration is 
maintained at high levels. It has been found that thiourea, the hydroxyl-radical scavenger, 
rescued M. smegmatis persister population even though DO was maintained at high levels. It 
should be noted that this relationship between oxygen and antibiotic sensitivity not only exists in 
mycobacteria but also in P. aeruginosa and E. coli. 
An alternative approach has been proposed to control P. aeruginosa PAO1 persister cells by 
using weak electrochemical currents alone or in combination with tobramycin [68]. For example, 
98% of P. aeruginosa PAO1 persister cells was reduced by the treatment with 70 μA/cm2 direct 
currents using stainless steel for 1 h compared to the untreated control.     
It also has been suggested that TA modules could be considered as potential targets for the 
development of novel antibiotics because the released toxins would kill bacterial cells [51, 69, 70]. 
Compounds that induce toxin activation might be useful as novel antibiotics [69]. 
1.3 Quorum sensing 
Quorum sensing (QS) is an important cell-to-cell communication system in bacteria, which 
regulates the expression of target genes in response to the cell population density [71-73]. It 
involves the formation and detection of signaling molecules termed autoinducers. When the 
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autoinducers reach a certain threshold concentration, the expression of target genes will be 
altered, such as those involved in the virulence factors, motility, competence, and biofilm 
formation [73-76]. 
1.3.1 Quorum sensing in Gram-negative bacteria 
In general, Gram-negative bacteria employ acylated homoserine lactones (acyl-HSLs or AHLs) 
as autoinducers. All AHLs have a basic structure of HSL ring and differ in the length of the R-
group side-chain ranging from 4 to 18 carbon atoms [77]. In AHL-mediated QS systems, the AHL 
signals are produced by autoinducer synthases (termed I proteins) and are recognized by cognate 
transcriptional regulatory proteins (termed R proteins) [77, 78]. QS System was first discovered in 
the Gram-negative bacterium Vibrio fischeri [72]. Three AHL signals have been found in V. 
fischeri, 3-oxo-hexanoly-HSL (produced by the LuxI protein and sensed by the LuxR protein), 
N-hexanoyl-L-HSL (produced by the LuxI protein and sensed by the LuxR protein), N-octanoyl-
HSL (produced by AinS protein and sensed by the LuxR protein) [78-80]. 
Two AHL QS systems have been found in P. aeruginosa: the las system and rhl system. The las 
system consists of the transcriptional regulatory protein LasR and autoinducer synthase LasI, 
which is responsible for the production of N-(3-oxododecanoyl)-HSL (3-oxo-C12-HSL) 
[81, 82]. 
The chemical structure of 3-oxo-C12-HSL is shown in Figure 1-1. This QS signal can freely 
diffuse into P. aeruginosa cells, while its transport to the extracellular environment relies on 
efflux pumps [83]. As the cell population density increases, the concentration of the autoinducer 
increases accordingly. When the autoinducer reaches a critical threshold concentration, the 
autoinducer binds to LasR protein and then forms LasR-autoinducer complex. This complex then 
triggers a series of target genes including genes encoding a number of virulence factors (for 
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example, genes toxA, lasA, lasB, and aprA) and other genes such as xcpR and xcpP [81, 83, 84]. 
Besides these genes, LasR-autoinducer complex also induces the expression of the lasI gene, 
which generates a positive feedback loop for signal production [81, 85]. It should be noted that the 
catabolite repressor homolog Vfr specifically binds to the lasR promoter and activate lasR 
transcription [86, 87]. Interestingly, RsaL protein encoded by the rsaL gene directly represses the 
transcription of the lasI gene, which generates a negative feedback loop and maintain 3-oxo-C12-
HSL homoeostasis [88, 89]. Meanwhile, RsaL protein also represses the production of virulence 
factors such as pyocyanin and hydrogen cyanide [88, 89]. 
 
 
Figure 1-1. Chemical structure of 3-oxo-C12-HSL.  
 
The rhl system consists of the RhlR protein and the autoinducer synthase RhlI, which is involved 
in the production of N-butyryl HSL (C4-HSL) 
[81]. The chemical structure of C4-HSL is shown in 
Figure 1-2. Unlike 3-oxo-C12-HSL, C4-HSL can freely diffuse both in and out of P. aeruginosa 
cells [83]. Analogous to the LasR-autoinducer complex, RhlR-autoinducer complex activates a 
number of genes such as rhlI, rpoS (which encodes the stationary phase sigma factor), lasB, 
rhlAB, and genes involved in pyocyanin biosynthesis [72].  
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Figure 1-2. Chemical structure of C4-HSL. 
 
As mentioned above, both the las system and the rhl system regulate the genes involved in 
virulence and biofilm formation. As shown in Figure 1-3, these two QS systems are not 
independent but hierarchically correlated because the LasR protein/3-oxo-C12-HSL could also 
positively regulate the rhlR and rhlI genes [81, 82]. It’s worth noticing that 3-oxo-C12-HSL 
competes with C4-HSL for binding to the receptor RhlR when the concentration of 3-oxo-C12-
HSL is higher than that of C4-HSL 
[81].  
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Figure 1-3. The las and rhl QS systems in P. aeruginosa. Plus symbols represent transcriptional 
activation of the genes at the end of an arrow. The symbol of “+/-?” represent the effect of the 
LasR/3-oxo-C12-HSL complex on lasR is unknown. The symbols of “-|”represent transcriptional 
repression of the genes. 
  
In P. aeruginosa, another QS system has been discovered that uses 2-heptyl-3-hydroxy-4-
quinolone (PQS) as the signaling molecule [90]. LasR protein is required for the production of the 
PQS autoinducer. Meanwhile, the PQS signal activates the transcription of the rhlI gene. 
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Therefore, the PQS QS system provides an additional link between the las system and the rhl 
system [72].  
1.3.2 Quorum sensing in Gram-positive bacteria 
Peptide signals are commonly used in QS systems of Gram-positive bacteria [75]. Unlike the 
AHL-mediated QS, peptide-mediated QS depends on two-component signal transduction 
systems. Peptide signals cannot diffuse across the cell membrane freely and their release relies 
on the dedicated peptide exporters [75]. A precursor peptide is produced and then modified and 
processed into mature peptide. ATP-Binding Cassette transporter complex can help the release of 
the mature peptide to the extracellular environment [73]. The concentration of QS peptides 
increases with the cell density. At high cell density, the mature peptides bind to the two-
component signal transduction system. Subsequently, a response regulator is phosphorylated and 
then binds to specific target promoters to regulate the expression of target genes.   
1.3.3 Quorum sensing and biofilm formation 
The role of QS systems in biofilm formation of Gram-negative bacteria has been extensively 
studied. QS signals are involved in the organization of P. aeruginosa biofilm structures [91]. 
Compared to the wild-type P. aeruginosa PAO1, double lasI-rhlI knockout mutant forms much 
thinner biofilms and the cells within biofilm are more densely packed [91]; these defects were 
rescued by adding the QS signal 3-oxo-C12-HSL. 
Burkholderia cepacia, a Gram-negative bacterium commonly found in the patients with cystic 
fibrosis, uses the cep QS system consisting of the transcriptional regulatory protein CepR and 
autoinducer synthase CepI [92]. Huber et al. [92] showed that the cep QS system plays an important 
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role in the maturation of B cepacia H111 biofilms. However, this QS system has no effect on the 
initial attachment of this strain [92]. 
In comparison, the role of QS systems in biofilm formation of Gram-positive bacteria is less 
understood. Petersen et al. [93] showed that exogenously added the competence stimulating 
peptide CSP significantly increases the production of S. intermedius biofilms. 
1.3.4 Quorum sensing inhibitors 
Since QS system is involved in the regulation of virulence factors and biofilm formation, 
interfering with QS system may be a promising strategy in the treatment of chronic infections. A 
variety of methods have been described to disrupt QS system such as interfering with the 
autoinducer receptors, inactivating or degrading the autoinducers, and disrupting the synthesis of 
QS autoinducers [78, 94, 95].  
1.3.4.1 Halogenated furanones  
More than 20 different brominated furanones are natural quorum sensing inhibitors (QSIs) 
produced by the marine red alga Delisea pulchra [96]. These furanones are located in the vesicles 
on the surface of the algea and exhibit a high level antifouling activity. They have chemical 
structures similar to AHLs, and thus were thought to disrupt QS completing with cognate AHL 
receptor proteins [97, 98].  
To date, the most extensively studied natural furanone is (5Z)-4-bromo-5-(bromomethylene)-3-
butyl-2(5H)-furanone (BF1). It has been shown that natural furanone is a QS signal antagonist 
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and inhibit biofilm formation and swarming of E. coli [99]. BF1 also exhibits inhibition activity 
on the biofilm formation of Gram-positive bacterium Bacillus subtilis [100]. 
A number of halogenated furanones have been synthesized and studied for the inhibition of 
biofilm formation by several bacterial species, such as S. aureus, E. coli, P. aeruginosa, S. 
epidermidis, and S. enterica serovar Typhimurium [37, 99-104]. Hentzer et al. [105] developed a novel 
synthetic furanone compound, called furanone C-30, which could inhibit P. aeruginosa QS, QS-
regulated virulence factors, biofilm development, and persistence of infecting bacteria in a 
pulmonary mouse model. Specifically, about 80% of the QS-regulated genes were remarkably 
repressed by this synthetic furanone [105]. In addition, a synthetic QSI, (Z)-4-bromo-5-
(bromomethylene)-3-methylfuran-2(5H)-one (BF8), has been reported to sensitize P. aeruginosa 
PAO1 and E. coli persisters to antibiotics [37, 101]. Furthermore, this chemical was found to inhibit 
biofilm formation and biofilm-associated persister cells of P. aeruginosa PDO300 [106].  
1.3.4.2 AHL analogues 
Based on the chemical structure of AHLs, several strategies have been described for the 
development of AHL analogs including modifications of the acyl side chain and alterations of 
HSL ring [94, 95, 107]. Persson et al. [108] reported that a series of sulfide AHL analogues 
significantly inhibit the transcriptional regulator LuxR and/or LasR. Smith et al. [109, 110] designed 
a library of synthetic AHL analogs in which the HSL group was modified to amines and alcohols. 
By screening this library, one compound with the HSL ring replaced a cyclohexane ring, showed 
significant inhibition of the production of virulence factors and biofilm formation [107, 109].    
1.3.4.3 AHL-degradation enzymes 
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A handful of enzymes that can degrade AHLs have been recently reported such as the AHL 
lactonase, the AHL acylase, and oxidoreductases [111, 112]. The first identified AHL lactonase, 
which could hydrolyze the lactone ring, is synthesized by the protein AiiA from Bacillus sp. 
240B1 [113]. AHL lactonases have also been characterized in other species such as Agrobacterium 
tumefacies, Bacillus thuringiensis, Bacillus anthracis, and P. aeruginosa PAO1 [114-117]. 
Another AHL-degrading enzyme is the AHL acylase that hydrolyzes the amide bond between 
HSL and acyl side chain. An AHL acylase encoded by AiiD of Ralstonia is capable of 
hydrolyzing long-chain AHLs such as 3-oxo-C8-HSL, 3-oxo-C10-HSL, and 3-oxo-C12-HSL 
[111, 
117]. In P. aeruginona PAO1, two AHL acylases encoded by the pvdQ gene (PA2385) and the 
quiP gene (PA1032) have been reported recently [117, 118]. These two enzymes also have the 
specific degradation activities for the long-chain AHL.   
 
References 
1. Davies, J. and D. Davies, Origins and evolution of antibiotic resistance. Microbiol Mol 
Biol Rev, 2010. 74(3): p. 417-33. 
2. Kohanski, M.A., et al., A common mechanism of cellular death induced by bactericidal 
antibiotics. Cell, 2007. 130(5): p. 797-810. 
3. Pankey, G.A. and L.D. Sabath, Clinical Relevance of Bacteriostatic versus Bactericidal 
Mechanisms of Action in the Treatment of Gram-Positive Bacterial Infections. Clin 
Infect Dis, 2004. 38: p. 864-870. 
   18 
 
4. Levy, S.B. and B. Marshall, Antibacterial resistance worldwide: causes, challenges and 
responses. Nat Med, 2004. 10(12 Suppl): p. S122-9. 
5. Lewis, K., Persister cells, dormancy and infectious disease. Nat Rev Microbiol, 2007. 
5(1): p. 48-56. 
6. Alanis, A.J., Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res, 
2005. 36(6): p. 697-705. 
7. Grant, S.S., et al., Eradication of bacterial persisters with antibiotic-generated hydroxyl 
radicals. Proc Natl Acad Sci U S A, 2012. 109(30): p. 12147-52. 
8. Wang, X. and X. Zhao, Contribution of oxidative damage to antimicrobial lethality. 
Antimicrob Agents Chemother, 2009. 53(4): p. 1395-402. 
9. Mazel, D. and J. Davies, Antibiotic resistance in microbes. CMLS. Cell. Mol. Life Sci., 
1999. 56: p. 742-754. 
10. Mecoy, L., Taming microbes to combat antibiotic resistance. Los Angeles Biomedical 
Research Institute at Harbor-UCLA Medical Center (LA BioMed), 2014. 
11. Bush, K., et al., Tackling antibiotic resistance. Nat Rev Microbiol, 2011. 9(12): p. 894-6. 
12. Levy, S.B., The challenge of antibiotic resistance. Scientific American, 1998: p. 46-53. 
13. Neu, H.C., The crisis in antibiotic resistance. Science 1992. 257: p. 1064-1073. 
14. Alekshun, M.N. and S.B. Levy, Molecular mechanisms of antibacterial multidrug 
resistance. Cell, 2007. 128(6): p. 1037-50. 
15. Kurosu, M., S. Siricilla, and K. Mitachi, Advances in MRSA drug discovery: where are 
we and where do we need to be? Expert Opin Drug Discov, 2013. 8(9): p. 1095-116. 
16. Hiramatsu, K., Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic 
resistance. The Lancet Infectious Diseases, 2001. 1(3): p. 147-155. 
   19 
 
17. Poole, K., et al., Multiple antibiotic resistance in Pseudomonas aeruginosa evidence for 
involvement of an efflux operon. J Bacteriol, 1993. 175(22): p. 7363-7372. 
18. Livermore, D.M., Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas 
aeruginosa: Our Worst Nightmare? Clin Infect Dis, 2002. 34: p. 634-640. 
19. Hancock, R.E.W., Resistance Mechanisms in Pseudomonas aeruginosa and Other 
Nonfermentative Gram-Negative Bacteria. Clin Infect Dis, 1998. 27: p. S93-99. 
20. Stoodley, P., et al., Biofilms as complex differentiated communities. Annu Rev microbiol, 
2002. 56: p. 187-209. 
21. Whitchurch, C.B., et al., Extracellular DNA required for bacterial biofilm formation. 
Science, 2002. 295: p. 1487. 
22. Mah, T.C. and G.A. O'Toole, Mechanisms of biofilm resistance to antimicrobial agents. 
Trends in Microbiol, 2001. 9: p. 34-39. 
23. Bryers, J.D., Medical biofilms. Biotechnol Bioeng, 2008. 100(1): p. 1-18. 
24. Fasani, R.A. and M.A. Savageau, Molecular mechanisms of multiple toxin-antitoxin 
systems are coordinated to govern the persister phenotype. Proc Natl Acad Sci U S A, 
2013. 110(27): p. E2528-37. 
25. Whiteley, M., et al., Gene expression in Pseudomonas aeruginosa biofilms. Nature, 2001. 
413: p. 860-864. 
26. Allesen-Holm, M., et al., A characterization of DNA release in Pseudomonas aeruginosa 
cultures and biofilms. Mol Microbiol, 2006. 59(4): p. 1114-28. 
27. Costerton, J.W., P.S. Stewart, and E.P. Greenberg, Bacterial bioﬁlms: a common cause of 
persistent infections. Science, 1999. 284: p. 1318-1322. 
   20 
 
28. Giwercman, B., et al., Induction of beta-lactamase production in Pseudomonas 
aeruginosa biofilm. Antimicrobial Agents and Chemotherapy, 1991. 35(5): p. 1008-1010. 
29. Hoyle, B.D., J. Alcantara, and J.W. Costerton, Pseudomonas aeruginosa biofilm as a 
diffusion barrier to piperacillin. Antimicrobial Agents and Chemotherapy, 1992. 36(9): p. 
2054-2056. 
30. Suci, P.A., et al., Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa 
biofilms. Antimicrobial Agents and Chemotherapy, 1994. 38(9): p. 2125-2133. 
31. Lewis, K., Riddle of biofilm resistance. Antimicrob Agents Chemother, 2001. 45(4): p. 
999-1007. 
32. Lewis, K., Persister cells and the riddle of biofilm survival. Biochemistry (Moscow) 2005. 
70(2): p. 267-274. 
33. Bigger, J.W., Treatment of staphylococcal infections with penicillin. Lancet, 1944. 244: p. 
497-500. 
34. Keren, I., et al., Characterization and transcriptome analysis of Mycobacterium 
tuberculosis persisters. MBio, 2011. 2(3): p. e00100-11. 
35. Fauvart, M., V.N. De Groote, and J. Michiels, Role of persister cells in chronic infections: 
clinical relevance and perspectives on anti-persister therapies. J Med Microbiol, 2011. 
60(Pt 6): p. 699-709. 
36. Dorr, T., M. Vulic, and K. Lewis, Ciprofloxacin causes persister formation by inducing 
the TisB toxin in Escherichia coli. PLoS Biol, 2010. 8(2): p. e1000317. 
37. Pan, J., et al., Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister 
cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One, 2012. 
7(9): p. e45778. 
   21 
 
38. Kwan, B.W., et al., Arrested protein synthesis increases persister-like cell formation. 
Antimicrob Agents Chemother, 2013. 57(3): p. 1468-73. 
39. Hu, Y. and A.R. Coates, Transposon mutagenesis identifies genes which control 
antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol Lett, 
2005. 243(1): p. 117-24. 
40. Spoering, A.L., M. Vulic, and K. Lewis, GlpD and PlsB participate in persister cell 
formation in Escherichia coli. J Bacteriol, 2006. 188(14): p. 5136-44. 
41. De Groote, V.N., et al., Novel persistence genes in Pseudomonas aeruginosa identified 
by high-throughput screening. FEMS Microbiol Lett, 2009. 297(1): p. 73-9. 
42. Lewis, K., Persister cells. Annu Rev Microbiol, 2010. 64: p. 357-72. 
43. Balaban, N.Q., et al., Bacterial persistence as a phenotypic switch. Science, 2004. 
305(5690): p. 1622-5. 
44. Shah, D., et al., Persisters: a distinct physiological state of E. coli. BMC Microbiol, 2006. 
6: p. 53. 
45. Allison, K.R., M.P. Brynildsen, and J.J. Collins, Heterogeneous bacterial persisters and 
engineering approaches to eliminate them. Curr Opin Microbiol, 2011. 14(5): p. 593-8. 
46. Janion, C., Inducible SOS Response System of DNA Repair and Mutagenesis in 
Escherichia coli. Int J Biol Sci, 2008. 4(6): p. 338-344. 
47. DÖrr, T., K. Lewis, and M. Vulić, SOS response induces persistence to fluoroquinolones 
in Escherichia coli. PLoS Genetics, 2009. 5(12). 
48. Pedersen, K. and K. Gerdes, Multiple hok genes on the chromosome of Escherichia coli. 
Molecular Microbiol, 1999. 32(5): p. 1090-1102. 
   22 
 
49. Singletary, L.A., et al., An SOS-regulated type 2 toxin-antitoxin system. J Bacteriol, 2009. 
191(24): p. 7456-65. 
50. Motiejunaite, R., et al., Escherichia coli dinJ-yafQ genes act as a toxin-antitoxin module. 
FEMS Microbiol Lett, 2007. 268(1): p. 112-9. 
51. Williams, J.J., et al., Toxin-antitoxin (TA) systems are prevalent and transcribed in 
clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus 
aureus. FEMS Microbiol Lett, 2011. 322(1): p. 41-50. 
52. Luiz, C.B.B., et al., Toxin-antitoxin systems and its biotechnological applications. 
African Journal of Biotechnology, 2014. 13(1): p. 11-17. 
53. Wang, X. and T.K. Wood, Toxin-antitoxin systems influence biofilm and persister cell 
formation and the general stress response. Appl Environ Microbiol, 2011. 77(16): p. 
5577-83. 
54. Buts, L., et al., Toxin-antitoxin modules as bacterial metabolic stress managers. Trends 
Biochem Sci, 2005. 30(12): p. 672-9. 
55. Gerdes, K. and E. Maisonneuve, Bacterial persistence and toxin-antitoxin loci. Annu Rev 
Microbiol, 2012. 66: p. 103-23. 
56. Jayaraman, R., Bacterial persistence some new insights into an old phenomenon. J. 
Biosci, 2008. 33(5): p. 795-805. 
57. Yamaguchi, Y. and M. Inouye, Regulation of growth and death in Escherichia coli by 
toxin-antitoxin systems. Nature Rev Microbiol, 2011. 9: p. 779-790. 
58. Vazquez-Laslop, N., H. Lee, and A.A. Neyfakh, Increased persistence in Escherichia coli 
caused by controlled expression of toxins or other unrelated proteins. J Bacteriol, 2006. 
188(10): p. 3494-7. 
   23 
 
59. Moyed, H.S. and K.P. Bertrand, hipA, a newly recognized gene of Escherichia coli K-12 
that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol, 
1983. 155(2): p. 768-775. 
60. Keren, I., et al., Specialized persister cells and the mechanism of multidrug tolerance in 
Escherichia coli. J Bacteriol, 2004. 186(24): p. 8172-80. 
61. Pandey, D.P. and K. Gerdes, Toxin-antitoxin loci are highly abundant in free-living but 
lost from host-associated prokaryotes. Nucleic Acids Res, 2005. 33(3): p. 966-76. 
62. Allison, K.R., M.P. Brynildsen, and J.J. Collins, Metabolite-enabled eradication of 
bacterial persisters by aminoglycosides. Nature, 2011. 473(7346): p. 216-20. 
63. Conlon, B.P., et al., Activated ClpP kills persisters and eradicates a chronic biofilm 
infection. Nature, 2013. 503(7476): p. 365-70. 
64. Gottesman, S., et al., The ClpXP and ClpAP proteases degrade proteins with carboxy-
terminal peptide tails added by the SsrA-tagging system. Genes Dev, 1998. 12(9): p. 
1338-47. 
65. Brotz-Oesterhelt, H., et al., Dysregulation of bacterial proteolytic machinery by a new 
class of antibiotics. Nat Med, 2005. 11(10): p. 1082-7. 
66. Sass, P., et al., Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell 
division protein FtsZ. PNAS, 2011. 108(42): p. 17474-9. 
67. Kim, J.S., et al., Selective killing of bacterial persisters by a single chemical compound 
without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother, 2011. 
55(11): p. 5380-3. 
   24 
 
68. Niepa, T.H., J.L. Gilbert, and D. Ren, Controlling Pseudomonas aeruginosa persister 
cells by weak electrochemical currents and synergistic effects with tobramycin. 
Biomaterials, 2012. 33(30): p. 7356-65. 
69. Gerdes, K., S.K. Christensen, and A. Lobner-Olesen, Prokaryotic toxin-antitoxin stress 
response loci. Nat Rev Microbiol, 2005. 3(5): p. 371-82. 
70. Williams, J.J. and P.J. Hergenrother, Exposing plasmids as the Achilles' heel of drug-
resistant bacteria. Curr Opin Chem Biol, 2008. 12(4): p. 389-99. 
71. Bassler, B.L., Small Talk: Cell-to-Cell Communication in Bacteria. Cell, 2002. 109: p. 
421-424. 
72. Miller, M.B. and B.L. Bassler, Quorum sensing in bacteria. Annu Rev Microbiol, 2001. 
55: p. 165-99. 
73. Waters, C.M. and B.L. Bassler, quorum sensing cell-to-cell communication in bacteria. 
Annual Review of Cell and Developmental Biology 2005. 21: p. 319-46. 
74. Rutherford, S.T. and B.L. Bassler, Bacterial quorum sensing: its role in virulence and 
possibilities for its control. Cold Spring Harb Perspect Med, 2012. 2(11). 
75. Schauder, S. and B.L. Bassler, The languages of bacteria. Genes Dev, 2001. 15(12): p. 
1468-80. 
76. Fuqua, C. and E.P. Greenberg, Listening in on bacteria: acyl-homoserine lactone 
signalling. Nat Rev Mol Cell Biol, 2002. 3(9): p. 685-95. 
77. Whitehead, N.A., et al., Quorum-sensing in Gram-negative bacteria. FEMS Microbiology 
Reviews 2001. 25: p. 365-404. 
78. Pan, J. and D. Ren, Quorum sensing inhibitors a patent overview. Expert Opin Ther 
Patents, 2009. 19(11): p. 1-21. 
   25 
 
79. Kuo, A., N.V. Blough, and P.V. Dunlap, Multiple N-Acyl-L-Homeserine lactone 
autoinducers of luminescence in the marine symbiotic bacterium Vibrio fischeri. J 
Bacteriol, 1994. 176(24): p. 7558-7565. 
80. Lupp, C. and E.G. Ruby, Vibrio fischeri LuxS and AinS: comparative study of two signal 
synthases. J Bacteriol, 2004. 186(12): p. 3873-81. 
81. Pesci, E.C., et al., Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. 
J Bacteriol, 1997. 179(10): p. 3127-3132. 
82. Delden, C.V. and B.H. Iglewski, Cell-to-Cell Signaling and Pseudomonas aeruginosa 
Infections. Emerging Infectious Diseases, 1998. 4(4): p. 551-560. 
83. Pearson, J.P., C. Van Delden, and B.H. Iglewski, Active efflux and diffusion are involved 
in transport of Pseudomonas aeruginosa cell-to-cell signals. J Bacteriol, 1999. 181(4): p. 
1203-10. 
84. Albus, A., Pesci EC, Runyen-Janecky LJ, West SEH, and Iglewski BH Vfr controls 
quorum sensing in Pseudomonas aeruginosa. J. Bacteriol., 1997. 179(12): p. 3928-3935. 
85. Seed, P.C., L. Passador, and B.H. Iglewski, Activation of the Pseudomonas aeruginosa 
lasI gene by LasR and the Pseudomonas autoinducer PAI an autoinducer regulatory 
hierarchy. J Bacteriol, 1995. 177(3): p. 654-659. 
86. Suh, J.H., et al., Effect of vfr mutation on global gene expression and catabolite 
repression control of Pseudomonas aeruginosa. Microbiol, 2002. 148(5): p. 1561-1569. 
87. Albus, A.M., et al., Vfr controls quorum sensing in Pseudomonas aeruginosa. J Bacteriol, 
1997. 179(12): p. 3928-3935. 
   26 
 
88. Rampioni, G., et al., RsaL provides quorum sensing homeostasis and functions as a 
global regulator of gene expression in Pseudomonas aeruginosa. Mol Microbiol, 2007. 
66(6): p. 1557-65. 
89. Kievit, T.D., et al., RsaL, a novel repressor of virulence gene expression in Pseudomonas 
aeruginosa. J Bacteriol, 1999. 181(7): p. 2175-2184. 
90. Pesci, E.C., et al., Quinolone signaling in the cell-to-cell communication system of 
Pseudomonas aeruginosa. Proc Natl Acad Sci U S A, 1999. 96: p. 11229-11234. 
91. Davies, D.G., The Involvement of Cell-to-Cell Signals in the Development of a Bacterial 
Biofilm. Science, 1998. 280(5361): p. 295-298. 
92. Huber, B., et al., The cep quorum-sensing system of Burkholderia cepacia H111 controls 
biofilm formation and swarming motility. Microbiol, 2001. 147: p. 2517-2528. 
93. Petersen, F.C., D. Pecharki, and A.A. Scheie, Biofilm mode of growth of Streptococcus 
intermedius favored by a competence-stimulating signaling peptide. J Bacteriol, 2004. 
186(18): p. 6327-31. 
94. Rasmussen, T.B. and M. Givskov, Quorum-sensing inhibitors as anti-pathogenic drugs. 
Int J Med Microbiol, 2006. 296(2-3): p. 149-61. 
95. Rasmussen, T.B. and M. Givskov, Quorum sensing inhibitors: a bargain of effects. 
Microbiology, 2006. 152(Pt 4): p. 895-904. 
96. de Nys, R., et al., New halogenated furanones from the marine alga delisea pulchra (cf. 
fimbriata). Tetrahedron, 1993. 49(48): p. 11213-11220. 
97. Givskov, M., et al., Eukaryotic interference with homoserine lactone-mediated 
prokaryotic signalling. J Bacteriol, 1996. 178(22): p. 6618-6622. 
   27 
 
98. Manefield, M., et al., Evidence that halogenated furanones from Delisea pulchra inhibit 
acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL 
signal from its receptor protein. Microbiol, 1999. 145: p. 283-91. 
99. Ren, D., J.J. Sims, and T.K. Wood, Inhibition of biofilm formation and swarming of 
Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Environ 
Microbiol, 2001. 3(11): p. 731-736. 
100. Ren, D., J.J. Sims, and T.K. Wood, Inhibition of biofilm formation and swarming of 
Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Letters 
in Applied Microbiol, 2002. 34: p. 293-299. 
101. Pan, J., et al., (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes 
Escherichia coli persister cells to antibiotics. Appl Microbiol Biotechnol, 2013. 97(20): p. 
9145-54. 
102. Hentzer, M., et al., Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm 
bacteria by a halogenated furanone compound. Microbiol, 2002. 148: p. 87-102. 
103. Janssens, J.C., et al., Brominated furanones inhibit biofilm formation by Salmonella 
enterica serovar Typhimurium. Appl Environ Microbiol, 2008. 74(21): p. 6639-48. 
104. Hume, E.B., et al., The control of Staphylococcus epidermidis biofilm formation and in 
vivo infection rates by covalently bound furanones. Biomaterials, 2004. 25(20): p. 5023-
30. 
105. Hentzer, M., et al., Attenuation of Pseudomonas aeruginosa virulence by quorum sensing 
inhibitors. The EMBO Journal, 2003. 22(15): p. 3803-3815. 
   28 
 
106. Pan, J., F. Song, and D. Ren, Controlling persister cells of Pseudomonas aeruginosa 
PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. Bioorg Med 
Chem Lett, 2013. 23(16): p. 4648-51. 
107. Kociolek, M.G., Quorum sensing inhibitors and biofilms. Anti-Infective Agents in 
Medicinal Chemistry, 2009. 8: p. 315-326. 
108. Persson, T., et al., Rational design and synthesis of new quorum-sensing inhibitors 
derived from acylated homoserine lactones and natural products from garlic. Org Biomol 
Chem, 2005. 3(2): p. 253-62. 
109. Smith, K.M., Y. Bu, and H. Suga, Induction and Inhibition of Pseudomonas aeruginosa 
Quorum Sensing by Synthetic Autoinducer Analogs. Chemistry & Biology, 2003. 10(1): 
p. 81-89. 
110. Smith, K.M., Y. Bu, and H. Suga, Library Screening for Synthetic Agonists and 
Antagonists of a Pseudomonas aeruginosa Autoinducer. Chemistry & Biology, 2003. 
10(6): p. 563-571. 
111. Dickschat, J.S., Quorum sensing and bacterial biofilms. Nat Prod Rep, 2010. 27(3): p. 
343-69. 
112. Dong, Y. and L. Zhang, Quorum sensing and quorum-quenching enzymes. The Journal 
of Microbiol, 2005. 43: p. 101-109. 
113. Dong, Y.H., et al., AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-
sensing signal and attenuates the virulence of Erwinia carotovora. Proc Natl Acad Sci U 
S A, 2000. 97(7): p. 3526-31. 
   29 
 
114. Carlier, A., et al., The Ti Plasmid of Agrobacterium tumefaciens Harbors an attM-
Paralogous Gene, aiiB, Also Encoding N-Acyl Homoserine Lactonase Activity. Applied 
and Environmental Microbiology, 2003. 69(8): p. 4989-4993. 
115. Dong, Y.H., et al., Identification of Quorum-Quenching N-Acyl Homoserine Lactonases 
from Bacillus Species. Applied and Environmental Microbiology, 2002. 68(4): p. 1754-
1759. 
116. Ulrich, R.L., Quorum quenching: enzymatic disruption of N-acylhomoserine lactone-
mediated bacterial communication in Burkholderia thailandensis. Appl Environ 
Microbiol, 2004. 70(10): p. 6173-80. 
117. Huang, J.J., et al., Utilization of Acyl-Homoserine Lactone Quorum Signals for Growth 
by a Soil Pseudomonad and Pseudomonas aeruginosa PAO1. Appl Environ Microbiol, 
2003. 69(10): p. 5941-5949. 
118. Huang, J.J., et al., Identification of QuiP, the product of gene PA1032, as the second 
acyl-homoserine lactone acylase of Pseudomonas aeruginosa PAO1. Appl Environ 
Microbiol, 2006. 72(2): p. 1190-7. 
 
 
 
             
 
 
 
 
   30 
 
 
 
 
 
 
CHAPTER 2 
EFFECTS OF N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE 
ON Pseudomonas aeruginosa PERSISTER CELLS 
   
 
 
 
 
 
 
 
 
 
 
 
 
   31 
 
2.1 Abstract 
Pseudomonas aeruginosa is a common Gram-negative pathogen that causes persistent lung 
infections in patients with cystic fibrosis. Here, we report that the quorum sensing signal N-(3-
oxododecanoyl)-homoserine lactone (3-oxo-C12-HSL), can sensitize P. aeruginosa (both the 
wild-type PAO1 and its mocoid mutant PDO300) persister cells to ciprofloxacin (Cip), but not 
gentamicin, tobramycin, carbenicillin. Also, the synergistic effects were only observed for 3-
oxo-C12-HSL, but not another quorum sensing signal N-butyryl homoserine lactone (C4-HSL). 
DNA microarrays and qPCR were used to understand the effects of 3-oxo-C12-HSL on gene 
expression of P. aeruginosa PAO1 persister cells. 
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2.2 Introduction 
Bacterial persistence is a phenomenon in which a small subpopulation of slow-growing or non-
growing cells, known as persister cells, is refractory to antibiotic treatment [1]. This phenomenon 
has been found in most bacterial species such as E. coli [2], P. aeruginosa [3], S. aureus [4], and M. 
tuberculosis [5]. A variety of factors has been linked in persister formation, including toxin-
antitoxin modules [6], starvation [7], heterogeneous growth [8], oxidative stress [9], SOS response 
[10], and phosphate metabolism [11, 12].  
P. aeruginosa is a common Gram-negative pathogen that causes lung infections in patients with 
cystic fibrosis and compromised immune systems [13]. According to the CDC National 
Nosocomial Infections Surveillance system from 1986-2003, P. aeruginosa is the fifth most 
commonly isolated organism responsible for 9% of hospital-acquired infections in the U.S. [14, 15]. 
Treatment of infectious diseases caused by P. aeruginosa has become more difficult due to rapid 
development of antibiotic-resistant strains. P. aeruginosa becomes multidrug resistant through 
different mechanisms such as overexpression of multidrug efflux pumps, genetic mutations, and 
horizontal transfer of drug resistance genes [16-18]. Besides these intrinsic resistance mechanisms, 
P. aeruginosa can also acquire multidrug tolerance by forming highly structured biofilms and 
dormant persister cells, which make the antibiotic treatment even more difficult. 
P. aeruginosa PDO300 (PDO300) is an isogenic mucA22 mutant of non-mucoid wild-type 
PAO1 [19]. The phenotypic difference between PDO300 and PAO1 is the overproduction of 
alginate in PDO300. This alginate overproduction was thought to influence the biofilm 
architecture and enhance the resistance of biofilm bacteria to antimicrobial agents [20]. 
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Quorum sensing (QS) is an important cell-to-cell communication system in bacteria, which 
regulates the expression of target genes in response to the cell population density. QS systems 
play a major role in the production of virulence factors and biofilm formation. In P. aeruginosa, 
there are two acylated homoserine lactone (acyl-HSL or AHL)-mediated QS systems: the las 
system and the rhl system. The las system consists of the transcriptional regulatory protein LasR 
and autoinducer synthase LasI, which produces the autoinducer N-(3-oxododecanoyl)-
homoserine lactone (3-oxo-C12-HSL) 
[21]. This autoinducer binds to LasR and then forms LasR-
autoinducer complex, which triggers a series of target genes including toxA, lasA, lasB, aprA, 
xcpR, and xcpP [22]. In addition, the LasR-autoinducer complex also induces the expression of 
lasI, which generates a positive feedback loop for signal production. Analogous to the las system, 
the rhl system is composed of the RhlR and the autoinducer synthase RhlI, which produces the 
signal N-butyryl HSL (C4-HSL). The RhlR-autoinducer complex activates a number of genes 
such as rhlI, rpoS, lasB, rhlAB, and some genes involved in pyocyanin biosynthesis [23, 24]. Two 
QS systems are hierarchically correlated because the LasR protein/3-oxo-C12-HSL complex 
could also induce rhlR and rhlI [22, 24]. It’s worth noticing that 3-oxo-C12-HSL competes with C4-
HSL for binding to the receptor RhlR when the concentration of 3-oxo-C12-HSL is higher than 
that of C4-HSL 
[22].  
Recently, Möker N et al. [25] reported that 3-oxo-C12-HSL significantly enhances the persister 
formation in exponential cultures of P. aeruginosa PAO1 and PA14 but not E. coli or S. aureus. 
In the present project, the effects of 3-oxo-C12-HSL and C4-HSL on P. aeruginosa PAO1 and 
PDO300 persister cells were tested. Our results show that 3-oxo-C12-HSL can enhance the 
susceptibility of PAO1 and PDO300 persister cells to Cip. In contrast, C4-HSL did not show any 
effect on the susceptibility of PAO1 and PDO300 persister cells to Cip. 
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2.3 Materials and methods 
2.3.1 Bacterial strain and growth media 
The wild-type P. aeruginosa PAO1 strain, lasR mutant, and rhlR mutant were purchased from 
the Manoil library at University of Washington [26]. PDO300 strain was obtained from Dr. 
Parseck at University of Washington. These strains and PDO300 were grown in the Luria-
Bertani (LB) medium containing 10 g/L NaCl, 10 g/L tryptone and 5 g/L yeast extract, and 
cultured with shaking at 200 rpm at 37ºC for 18 h. 
2.3.2 Chemicals 
The QS signals of 3-oxo-C12-HSL and C4-HSL were ordered from Sigma-Aldrich Co. (St. Louis, 
MO, USA) and Cayman Chemical Co. (Ann Arbor, MI, USA), respectively. These two 
chemicals were dissolved in dimethyl sulfoxide (DMSO) (MP Biomedicals, LLC, Santa Ana, 
CA, USA) to the concentration of 5 mg/ml.  
2.3.3 Persister isolation 
Overnight culture of PAO1 or PDO300 persister cells were isolated by killing the normal cells 
with 200 μg/mL Cip for 3.5 h [27, 28]. After the treatment, the surviving persister cells were 
washed three times with 0.85% NaCl solution and then resuspended in 0.85% NaCl solution. The 
isolated persister cells were then treated with different AHLs shown as below. The cells after 
each treatment were further challenged with 200 μg/mL Cip for 3.5 h. Then the samples were 
washed three times with 0.85% NaCl solution and plated on LB agar plates (1.5% agar) after a 
series of lot dilution to determine the colony forming units (CFU) [29]. 
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2.3.4 Effects of 3-oxo-C12-HSL on isolated PAO1 or PDO300 persister cells 
Persister cells were isolated from overnight cultures of PAO1 or PDO300 as described above. 
The isolated persister cells were diluted by 50 times with 0.85% NaCl solution and then treated 
with different concentrations of 3-oxo-C12-HSL. The amount of DMSO was adjusted to be the 
same in all samples to eliminate any solvent effect. All samples were incubated at 37ºC for 2 h 
with shaking at 200 rpm. After the 2 h treatment, 1 mL of each sample was withdrawn and 
washed three times with 0.85% NaCl solution. Then cells were diluted and plated on LB agar 
plates. Meanwhile, the remaining portion of each sample was further challenged with 200 μg/mL 
Cip for 3.5 h. Each sample was then tested to determine the CFU as described above. This 
experiment was conducted with two biological replicates. The effects on QS mutants were tested 
using the same method. 
2.3.5 Effects of 3-oxo-C12-HSL on antibiotic susceptibility of isolated PAO1 or PDO300 
persister cells 
PAO1 or PDO300 persister cells were isolated by killing the normal cells with 200 μg/mL Cip 
for 3.5 h and then diluted by 50 times with 0.85% NaCl solution. PAO1 persisters were treated 
with different concentrations of 3-oxo-C12-HSL. After 2 h of incubation, 1 mL of each sample 
was washed three times with 0.85% NaCl solution and plated to count CFU. The remaining 
portion of each sample was further challenged with 5 μg/mL ofloxacin (Ofl), 200 μg/mL 
tobramycin (Tob), 500 μg/mL carbenicillin (Car), 200 μg/mL gentamicin (Gen), or 200 μg/mL 
tetracycline (Tet) for another 3.5 h. Then each sample was tested to determine the CFU as 
described above. This experiment was conducted with two biological replicates. 
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2.3.6 Effects of C4-HSL on isolated PAO1 or PDO300 persister cells 
This experiment was conducted by following the same protocol as described for the test of 3-
oxo-C12-HSL. The QS signal C4-HSL was tested at 0, 5, 10, 15, and 30 μg/mL. This experiment 
was conducted with two biological replicates. The effects on QS mutants were tested using the 
same method. 
2.3.7 RNA extraction and microarray analysis 
Overnight cultures of PAO1 were grown with agitation (200 rpm) in LB medium at 37ºC for 18 
h. Persister cells were isolated from overnight cultures as described above. The isolated 
persisters were diluted by 5 times with 0.85% NaCl solution and then treated with 100 μg/ml 3-
oxo-C12-HSL at 37ºC for 1 h. After 1 h treatment, cells were pelleted by centrifugation at 2ºC for 
2 min at 10,000 rpm and the supernatant was discarded. The cell pellets were frozen instantly in 
a dry ice-ethanol bath and then stored at -80ºC. 
Total RNA from the persister cells was extracted using RNeasy Mini Kit (Qiagen, Austin, TX, 
USA) with on-column DNase I treatment (RNase-Free DNase Set, Qiagen) by following the 
manufacturer’s instructions. The integrity of RNA samples was determined by gel 
electrophoresis. RNA samples were stored at -80ºC until sent to the DNA Microarray Facility at 
SUNY Upstate Medical University (Syracuse, NY, USA) for hybridization on GeneChip P. 
aeruginosa Genome Array (P. aeruginosa Genome Array, Affymetrix, Santa Clara, CA, USA) 
which contained probes for all the 5570 predicted PAO1 genes. This experiment was conducted 
with two biological replicates. 
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2.3.8 Quantitative PCR analysis  
The DNA microarray results were validated by quantitative PCR (qPCR) analysis. The rpoD 
gene was used as the house-keeping gene as described previously [30]. Total RNA was extracted 
as mentioned above and then reverse transcribed into cDNA by using iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA, USA). All reactions were conducted in a C1000 Touch Thermal Cycler 
(Bio-Rad, Hercules, CA, USA) with the following steps: 25ºC for 5 min, 42ºC for 30 min, 85ºC 
for 5 min, and holding at 4ºC. The concentration of cDNA was determined using the 
Evolution201 UV-Visible spectrophotometer (Thermo Scientific, Waltham, MA, USA). Then 
cDNA was stored at -20ºC. Based on genomic sequence of PAO1 listed in NCBI, qPCR primers 
for genes of interest were designed using OligoAnalyzer 3.1 software (Integrated DNA 
Technologies, Coralville, IA, USA). Primers were designed to yield PCR products of 225-275 bp 
with melting temperature around 60ºC. The selected genes and primer sequences were listed in 
Table 2-1. To verify primer specificity, regular PCR reactions using Taq polymerase were run at 
94ºC for 2 min followed by 30 cycles of 94ºC for 15 s, 60ºC for 15 s, and 68ºC for 30 s; and one 
final extension step at 68ºC for 5 min. iTaq Universal SYBR Green Supermix (Bio-Rad, 
Hercules, CA, USA) was used to detect any double-stranded DNA. All reactions were conducted 
in white 96-well plates. A negative control (cDNA samples without forward and reverse primers) 
was also included in all qPCR runs. The qPCR reactions were run using a Mastercycler ep 
realplex (Eppendorf, Hauppauge, NY, USA) with the following thermo cycling program: initial 
DNA denaturation at 95ºC for 2 min, followed by 40 cycles of denaturation at 95ºC for 15 sec, 
annealing at 60ºC (or 61ºC) for 1 min, and extension at 50ºC for 30 sec. qPCR was performed 
with three biological replicates. Data analysis was performed using the LinRegPCR program. 
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Table 2-1. Genes and specific primers used for qPCR analysis. 
Gene Primer sequence (5'-3') Product size (bp) 
rpoD  (+)CGGTCAACCTGAAGGACGAT 253 
(-)ACCAGCTTGATCGGCATGAA 
rsaL  
 
(+)AGCAATGGCTTCACACGAGA 239 
(-)TGATCTTGCCTCTCAGGTCG 
mvaT  
 
(+)TCTACTTACATGCCCGCCAC 229 
(-)CGGATCGAGCAGGGAAATCA 
folD  
 
(+)CCTCTCAGGTCTATGTGGCG 251 
(-)GCCGATGTTGTAGGGATGGA 
phoU  
 
(+)CAGCGGCTCCAGAAGGATTC 226 
(-)GCGCTCCATCTGGTTGATCT 
hmgA  
 
(+)CACCTGGCTGTACCGCATC 256 
(-)GTCGTAGAAGCAACGCTCCA 
pilH  
 
(+)GCATGGTCACCAGGTACTCAA 268 
(-)CAGCAGGGTCTCTTCGTCC 
 
2.3.9 Statistical analysis 
Statistical analysis was conducted using SAS 9.1.3 Windows version (SAS, Cary, NC, USA) to 
compare the difference between the control and treatment samples. The notes of *, **, and *** 
indicate that the p-value is <0.05, <0.01, and <0.001, respectively. 
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2.4 Results 
2.4.1 Effects of 3-oxo-C12-HSL on PDO300 persister cells  
First, we tested if 3-oxo-C12-HSL can affect the viability of PDO300 persister cells and their 
susceptibility to Cip. As shown in Figure 2-1, 3-oxo-C12-HSL did not affect the viability of 
PDO300 persister cells (One-way ANOVA, p=0.6879). Interestingly, 3-oxo-C12-HSL increased 
the susceptibility of isolated PDO300 persister cells to Cip dose dependently (5-30 μg/mL). For 
instance, 10 μg/mL and 30 μg/mL 3-oxo-C12-HSL sensitized 53% ± 32% and 91.1% ± 12% of 
PDO300 persister cells to Cip, respectively. 
 
Figure 2-1. Effects of 3-oxo-C12-HSL on PDO300 persister cells. Open bars represent the total 
number of viable cells after treatment with 3-oxo-C12-HSL. Shaded bars represent the number of 
cells that remained viable after treatment with 200 μg/mL Cip. The persister cells were treated 
with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of each sample was further 
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challenged with 200 μg/mL Cip for 3.5 h to determine the number of viable cells. The number of 
viable cells of untreated controls were normalized to 100%.  
 
To determine if 3-oxo-C12-HSL can also sensitize PDO300 persister cells to other antibiotics, we 
repeated the above experiment by replacing Cip with antibiotics that target protein synthesis (Tet, 
Tob, and Gen) and cell wall synthesis (Car). As shown in Figures 2-2 to 2-6, we found that 3-
oxo-C12-HSL didn’t affect the susceptibility of PDO300 persister cells to these four antibiotics. 
This suggests that the synergy may be specific to a small group of antibiotics. 
 
Figure 2-2. Effects of 3-oxo-C12-HSL on PDO300 persister cells by using 25 μg/mL Tob. The 
persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of 
each sample was further challenged with 25 μg/mL Tob for 3.5 h to determine the number of 
viable cells. The number of viable cells of untreated controls were normalized to 100%.  
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Figure 2-3. Effects of 3-oxo-C12-HSL on PDO300 persister cells by using 200 μg/mL Tob. The 
persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of 
each sample was further challenged with 200 μg/mL Tob for 3.5 h to determine the number of 
viable cells. The number of viable cells of untreated controls were normalized to 100%. 
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Figure 2-4. Effects of 3-oxo-C12-HSL on PDO300 persister cells by using 200 μg/mL Gen. The 
persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of 
each sample was further challenged with 200 μg/mL Gen for 3.5 h to determine the number of 
viable cells. The number of viable cells of untreated controls were normalized to 100%. 
 
 
Figure 2-5. Effects of 3-oxo-C12-HSL on PDO300 persister cells by using 25 μg/mL Tet. The 
persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of 
each sample was further challenged with 200 μg/mL Tet for 3.5 h to determine the number of 
viable cells. The number of viable cells of untreated controls were normalized to 100%. 
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Figure 2-6. Effects of 3-oxo-C12-HSL on PDO300 persister cells by using 500 μg/mL Car. The 
persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of 
each sample was further challenged with 500 μg/mL Car for 3.5 h to determine the number of 
viable cells. The number of viable cells of untreated controls were normalized to 100%. 
 
2.4.2 Effects of C4-HSL on PDO300 persister cells  
Unlike 3-oxo-C12-HSL, another QS signal C4-HSL did not exhibit the same effect. As shown in 
Figure 2-7, C4-HSL did not significantly change the viability of PDO300 or its susceptibility to 
Cip. 
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Figure 2-7. Effects of C4-HSL on PDO300 persister cells. The persister cells were treated with 
C4-HSL at different concentrations for 2 h. A portion of each sample was further challenged with 
200 μg/mL Cip for 3.5 h to determine the number of viable cells. The number of viable cells of 
untreated controls were normalized to 100%. 
 
To corroborate the results, we also tested the mixture of 3-oxo-C12-HSL and C4-HSL at different 
ratios. As shown in Figure 2-8, when the concentration of 3-oxo-C12-HSL in the mixture was 15 
μg/mL, 66% ± 23.9% of isolated PDO300 persister cells were sensitized to Cip (One-way 
ANOVA, p<0.0001). At the higher concentration of 3-oxo-C12-HSL, e.g., 35 μg/mL, 98.7% ± 
1.5% of PDO300 persister cells were sensitized to Cip (One-way ANOVA, p<0.0001). 
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Figure 2-8. Effects of 3-oxo-C12-HSL and C4-HSL on PDO300 persister cells. The persister cells 
were treated with the mixture of 3-oxo-C12-HSL and C4-HSL at different concentrations for 2 h. 
A portion of each sample was further challenged with 200 μg/mL Cip for 3.5 h to determine the 
number of viable cells. The number of viable cells of untreated controls were normalized to 
100%. 
 
2.4.3 Effects of 3-oxo-C12-HSL on PAO1 persister cells  
Based on the above results, we were motivated to test if 3-oxo-C12-HSL has the similar effect on 
P. aeruginosa PAO1 persister cells. As shown in Figure 2-9, 3-oxo-C12-HSL increased the 
susceptibility of PAO1 persister cells to Cip in a dose-dependent manner (5-30 μg/mL). For 
instance, 5 μg/mL 3-oxo-C12-HSL did not affect the viability of persisters but sensitized 72% ± 
13% of persister cells to Cip (One-way ANOVA, p < 0.001). When the concentration of 3-oxo-
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C12-HSL reached 30 μg/mL, 92% ± 8% of PAO1 persisters became susceptible to the treatment 
of Cip (One-way ANOVA, p < 0.001), although the viability of PAO1 persister cells were not 
significantly affected by 3-oxo-C12-HSL alone. 
 
Figure 2-9. Effects of 3-oxo-C12-HSL on P. aeruginosa PAO1 persister cells. The persister cells 
were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A portion of each sample 
was further challenged with 200 μg/mL Cip for 3.5 h to determine the number of viable cells. 
The number of viable cells of untreated controls were normalized to 100%. 
 
To test if 3-oxo-C12-HSL can potentiate PAO1 persister cells to other antibiotics, we tested three 
types of antibiotics including quinolone (Ofl), aminoglycoside (Tob), and Car. As shown from 
Figure 2-10 to Figure 2-12, 3-oxo-C12-HSL did not potentiate these hree antibiotics based on the 
statistical analysis. 
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
0 5 10 15 30
Total number of viable cells after treatment with 3-oxo-C12-HSL
Total number of cells that remained as viable after treatment with Cip
Concentration of 3-oxo-C12-HSL (µg/mL)
C
el
l 
n
u
m
b
er
/m
L
***
***
***
**
**
**
**
   47 
 
 
Figure 2-10. Effects of 3-oxo-C12-HSL on P. aeruginosa PAO1 persister cells by using 5 μg/ml 
Ofl. The persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 h. A 
portion of each sample was further challenged with 5 μg/ml Ofl for 3.5 h to determine the 
number of viable cells. The number of viable cells of untreated controls were normalized to 
100%. 
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Figure 2-11. Effects of 3-oxo-C12-HSL on P. aeruginosa PAO1 persister cells by using 200 
μg/ml Tob. The persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 
h. A portion of each sample was further challenged with 200 μg/ml Tob for 3.5 h to determine 
the number of viable cells. The number of viable cells of untreated controls were normalized to 
100%. 
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Figure 2-12. Effects of 3-oxo-C12-HSL on P. aeruginosa PAO1 persister cells by using 500 
μg/ml Car. The persister cells were treated with 3-oxo-C12-HSL at different concentrations for 2 
h. A portion of each sample was further challenged with 500 μg/ml Car for 3.5 h to determine the 
number of viable cells. The number of viable cells of untreated controls were normalized to 
100%. 
 
2.4.4 Effects of C4-HSL on PAO1 persister cells  
Unlike 3-oxo-C12-HSL, C4-HSL did not sensitize PAO1 persister cells to Cip (Figure 2-13). As 
described above, this QS signal also did not show any effect on the susceptibility of PDO300 
persister cells to Cip. 
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Figure 2-13. Effects of C4-HSL on P. aeruginosa PAO1 persister cells. The persister cells were 
treated with C4-HSL at different concentrations for 2 h. A portion of each sample was further 
challenged with 200 μg/ml Cip for 3.5 h to determine the number of viable cells. The number of 
viable cells of untreated controls were normalized to 100%. 
 
2.4.5 Effects of 3-oxo-C12-HSL on persister cells of PAO1 lasR and rhlR mutants 
Since LasR and RhlR are receptors of 3-oxo-C12-HSL and C4-HSL, respectively, we also 
evaluated the effects of 3-oxo-C12-HSL on persister cells of PAO1 lasR and rhlR mutants. As 
shown in Figure 2-14, 3-oxo-C12-HSL at 30 μg/mL can also sensitize 39.0% ± 46.3% of PAO1 
lasR mutant persisters to Cip. Similarly, 52.1% ± 10.1% of PAO1 rhlR mutant persisters became 
susceptible to the treatment of Cip (Figure 2-15). However, the synergistic effect on persisters of 
these two mutants was less than that on wild-type PAO1. These results suggest that the 
synergistic effect may be through the regulatory proteins LasR and RhlR. 
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Figure 2-14. Effects of 3-oxo-C12-HSL on persister cells of P. aeruginosa PAO1 lasR mutant. 
The persister cells of lasR mutant were isolated from an 18 h overnight culture and treated with 
3-oxo-C12-HSL at different concentrations for 2 h. A portion of each sample was further 
challenged with 200 μg/ml Cip for 3.5 h to determine the number of viable cells. The number of 
viable cells of untreated controls were normalized to 100%. 
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Figure 2-15. Effects of 3-oxo-C12-HSL on persister cells of P. aeruginosa PAO1 rhlR mutant. 
The persister cells of rhlR mutant were isolated from an 18 h overnight culture and treated with 
3-oxo-C12-HSL at different concentrations for 2 h. A portion of each sample was further 
challenged with 200 μg/ml Cip for 3.5 h to determine the number of viable cells. The number of 
viable cells of untreated controls were normalized to 100%. 
 
2.4.6 Effects of C4-HSL on persister cells of PAO1 lasR and rhlR mutants 
As shown in Figure 2-16 and Figure 2-17, C4-HSL also showed no effect on the susceptibility of 
persister cells of the lasR and rhlR mutants to Cip. 
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Figure 2-16. Effects of C4-HSL on persister cells of P. aeruginosa PAO1 lasR mutant. The 
persister cells of lasR mutant were isolated from an 18 h overnight culture and treated with C4-
HSL at different concentrations for 2 h. A portion of each sample was further challenged with 
200 μg/ml Cip for 3.5 h to determine the number of viable cells. The number of viable cells of 
untreated controls were normalized to 100%. 
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Figure 2-17. Effects of C4-HSL on persister cells of P. aeruginosa PAO1 rhlR mutant. The 
persister cells of rhlR mutant were isolated from an 18 h overnight culture and treated with C4-
HSL at different concentrations for 2 h. A portion of each sample was further challenged with 
200 μg/ml Cip for 3.5 h to determine the number of viable cells. The number of viable cells of 
untreated controls were normalized to 100%. 
 
2.4.7 DNA Microarray Analysis 
As mentioned above, 3-oxo-C12-HSL only showed the synergistic effect with the antibiotic Cip 
in killing P. aeruginosa PAO1 persister cells, but not the other three antibiotics tested such as 
Ofl, Tob, and Car. In order to obtain insights into how 3-oxo-C12-HSL rendered PAO1 persister 
cells sensitive to Cip, we used the DNA microarray to understand the effects of 3-oxo-C12-HSL 
on gene expression in PAO1 persister cells. P. aeruginosa microarrays were employed to 
compare gene expression in persister cells without or with 3-oxo-C12-HSL. These microarrays 
include 5570 predicted PAO1 genes. The transcriptome analysis of PAO1 persister cells treated 
with and without 100 μg/ml 3-oxo-C12-HSL for 1 h was performed in duplicate. 
Overall, 144 genes showed a gene expression ratio higher than 1.5 fold in response to 3-oxo-C12-
HSL. Among these 144 genes, 59 genes were upregulated and 85 genes were downregulated by 
the treatment of 3-oxo-C12-HSL. Approximately, 46% of the 144 genes encode hypothetical 
proteins (Figure 2-18). Some representative induced and repressed genes is shown in Table 2-2. 
Importantly, the genes parC (PA4964) and parE (PA4967), which encode the subunit A and B of 
the topoisomerase IV (one target of Cip) [31], were upregulated in our microarray data. 
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Figure 2-18. Transcriptome profile analysis of P. aeruginosa PAO1 persister cells treated with 3-
oxo-C12-HSL. The isolated persisters were treated with and without 100 μg/ml 3-oxo-C12-HSL 
for 1 h.  
 
To confirm the DNA microarray results, we performed the real-time PCR analysis for seven 
genes including one housekeeping gene (rpoD), 3 induced genes (rsaL, mvaT, and folD), and 3 
repressed genes (phoU, pilH, and hmgA). As shown in Figure 2-19, the qPCR results of these 
seven genes are consistent with the DNA microarray data. For example, the rsaL gene, which 
encodes a repressor of lasI gene and virulence genes encoding pyocyanin and hydrogen cyanide 
(phz1 and phz2 operons, phzM, phzS, and hcnABC) [32, 33], was induced by about 4 times as 
shown in our microarray data. Pyocyanin is a toxin produced by P. aeruginosa that affects 
multiple cellular processes such as cell respiration, ciliary function, and cell growth [34]. Thus, it 
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plays important roles in the pathogenesis mediated by P. aeruginosa [34]. The induction of rsaL 
may reduce the production of pyocyanin and hydrogen cyanide and thus repress the 
pathogenicity of PAO1. Another induced gene mvaT is thought to be a global regulator of 
virulence genes (pyocyanin and elastase) and the lecA gene (coding for PA-IL lectin) because 
inactivation of mvaT resulted in increased lecA expression and pyocyanin production [35]. The 
induction of mvaT gene may decrease pyocyanin production and result in reduction of PAO1 
pathogenicity. For the repressed gene phoU, one recent study showed that this gene is involved 
in the persistence of E. coli [12]. Inactivation of PhoU resulted in the high metabolic activity in E. 
coli and thus reduced persister formation [12]. 
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Figure 2-19. qPCR validation of microarray results for selected genes. (A) Shaded and closed bars 
represent the mean PCR efficiency of seven genes (rpoD, rsaL, mvaT, folD, phoU, hmgA, and pilH) in the 
control and 3-oxo-C12-HSL treated samples, respectively. The rpoD gene is the housekeeping gene used 
in qPCR. (B) Grey bars represent the fold change of six genes including rsaL, mvaT, folD, phoU, hmgA, 
and pilH shown in qPCR result. 
 
2.5 Discussion 
In this study, we found that 3-oxo-C12-HSL can increase the susceptibility of P. aeruginosa 
PDO300 persister cells to Cip. Statistical analysis showed that 3-oxo-C12-HSL didn’t affect the 
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viability of PDO300 persister cells at the range of concentrations tested from 5 to 30 μg/ml. It is 
interesting that no synergy was observed between 3-oxo-C12-HSL and other classes of antibiotics 
including Tet, Tob, Gen, and Car. Tet, Tob, Gen target bacterial protein synthesis while Car 
targets bacterial cell wall synthesis [36, 37]. In addition, our results showed that 3-oxo-C12-HSL 
can also render P. aeruginosa PAO1 persisters susceptible to the antibiotic Cip. However, such 
synergy was not found between 3-oxo-C12-HSL and the other three antibiotics tested with targets 
of DNA synthesis (Ofl), protein synthesis (Tob), and cell wall synthesis (Car). We hypothesize 
that 3-oxo-C12-HSL may interact with Cip or its cellular target; and thus, sensitize PDO300 
persister cells to Cip. Further studies of such interactions are helpful for understanding the 
mechanism. 
Unlike 3-oxo-C12-HSL, C4-HSL did not exhibit any synergistic effect with Cip in killing 
PDO300 persister cells. This phenomenon was observed in PAO1 persister cells as well. Two QS 
signals, 3-oxo-C12-HSL and C4-HSL, have the same homoserine lactone ring but differ in the 
number of carbon atoms in the side-chain. This may be responsible for the difference in 
interaction with Cip and consequently their synergistic effects in persister control with Cip. 
Recently, Pan et al. [27] reported that (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-25(H)-one 
(BF8), as a synthetic QS inhibitor, can restore the antibiotic susceptibility of P. aeruginosa 
PAO1 persister cell. 
In P. aeruginosa, RsaL protein encoded by the rsaL gene was well characterized as a repressor 
of lasI gene encoding the 3-oxo-C12-HSL signal synthase 
[32, 33]. In addition, RsaL can bind 
simultaneously with LasR to the rsaL-lasI bidirectional promoter thereby to the LasR-dependent 
activation of both genes. Besides, RsaL also has direct or indirect controls of some genes via 
   59 
 
auxiliary regulators [32]. Therefore, as the global regulatory factor, the expression of rsaL is 
essential to modulate of the homeostasis of 3-oxo-C12-HSL and QS circuits involved metabolic 
status change [38]. The persister specific induction of rsaL upon 3-oxo-C12-HSL, as observed in 
our study, suggests that excess 3-oxo-C12-HSL may perturb the rsal-lasI-involved QS network 
and impact the transition between planktonic and sessile status to sensitize persister cells.  
Of interest, the phoU gene was repressed three times by 3-oxo-C12-HSL in PAO1 persister cells 
as shown from our microarray analysis. The phoU gene encodes the phosphate uptake regulatory 
protein PhoU; it is expressed together with other four genes for the ABC-type phosphate-specific 
transport (PstSABC) within the pstSCAB–phoU operon [39, 40]. The Pst-PhoU complex was 
known to play roles in phosphate sensing and eventual modulate QS network through MvfR and 
PQS [41]. In a previous study by Li et al. [12], the phoU gene has been shown to control persister 
formation and multidrug tolerance in E. coli. Compared to the wild-type strain E. coli K-12 
W3110, phoU mutant becomes more susceptible to different antibiotics, such as gentamicin and 
norfloxacin, and stresses including starvation, heat, and acid pH [12]. P. aeruginosa has a phoU 
homolog in its genome [42, 43]. Therefore, inhibition of phoU by 3-oxo-C12-HSL in PAO1 
persister cells may initiate the phoU regulon through phoR/B two component system and 
ultimately alter metabolism like in E. coli [44], or QS signaling and switch between 
sessile/virulent life cycle [40, 45]. 
To date, only a few persistence genes have been described in P. aeruginosa including spoT, relA, 
dksA, rpoS, dinG, spuC, pilH, and PA5002 [46]. Earlier studies have shown that PA5002 is part of 
a larger gene cluster that span PA5012-PA4995 of PAO1 genome, which is associated with the 
production of P. aeruginosa core oligosaccharide biosynthesis genes [47]. The gene adjacent to 
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PA5002, was characterized as a Mig-14-like protein required for the formation of antimicrobial 
peptide-tolerant subpopulations [48]. In a recent study by Liebens et al. [49], the gene locus 
PA5002 was identified as a de-N-acetylase (dnpA) and was involved in the fluoroquinolone 
tolerance in P. aeruginosa. This was evidenced by the decrease of fluoroquinolone tolerance in 
PA5002 mutant (both in planktonic culture and biofilm model) while increase of persister 
fraction in dnpA-overexpressing strain. Concurrent with our transcriptome analysis result that 3-
oxo-C12-HSL reduced dnpA expression by 3-fold, it supports the hypothesis that the reduced 
expression of PA5002 (dnpA) by 3-oxo-C12-HSL diminished the ciprofloxacin persistence 
through mediating the genes for surface associated processes [49].  
In addition, we found that the genes parC and parE, which encode topoisomerase IV that is the 
target of the antibiotic Cip [31], were induced in our microarray data. We hypothesize that 
induction of one Cip target by 3-oxo-C12-HSL may also help increase the susceptibility of PAO1 
persister cells to Cip.  
In conclusion, the results indicate that 3-oxo-C12-HSL can render P. aeruginosa PAO1 persister 
cells sensitive to the antibiotic Cip. This effect is not directly through lasR and rhlR. Further 
studies are needed to understand the underlying mechanism. 
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Table 
Table 2-2. Induced and repressed genes by 3-oxo-C12-HSL in P. aeruginosa PAO1 persister cells. 
Microarray data were analyzed from two biological replicates. 
Gene name 
Accession 
number 
Expression 
ratio 
Function 
rsaL PA1431 4.07 
Adaptation, protection; 
Transcriptional regulators; Secreted 
Factors (toxins, enzymes, alginate) 
mvaT PA4315 2.07 Transcriptional regulators 
folD PA1976 3.03 
Nucleotide biosynthesis and 
metabolism; Biosynthesis of 
cofactors, prosthetic groups and 
carriers; Translation, post-
translational modification, 
degradation 
ppx PA5241 2.46 
Adaptation, protection; Nucleotide 
biosynthesis and metabolism 
Probable 
transcriptional 
regulator 
PA3973 2.76 Transcriptional regulators 
Probable 
transcriptional 
regulator 
PA0279 10.25 Transcriptional regulators 
coaD PA0363 2.50 Central intermediary metabolism 
metH PA1843 3.15 
Amino acid biosynthesis and 
metabolism 
etfA PA2951 2.13 Energy metabolism 
masA PA1685 1.84 Amino acid biosynthesis and 
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metabolism 
azu PA4922 1.84 Energy metabolism 
pssA PA4693 1.92 
Fatty acid and phospholipid 
metabolism 
parC PA4964 1.50 topoisomerase IV subunit A  
parE PA4967 1.98 topoisomerase IV subunit B 
Probable 
cytochrome c 
PA1555 2.63 Energy metabolism 
Hypothetical 
protein 
PA2433 2.95 Hypothetical, unclassified, unknown 
Hypothetical 
protein 
PA0737 2.79 Hypothetical, unclassified, unknown 
Hypothetical 
protein 
PA2243 2.54 Hypothetical, unclassified, unknown 
phoU PA5365 0.34 
Membrane proteins; Transcriptional 
regulators 
pilH PA0409 0.45 
Chemotaxis; Two-component 
regulatory systems; Motility & 
Attachment 
hmgA PA2009 0.30 Carbon compound catabolism 
gcdH PA0447 0.31 
Amino acid biosynthesis and 
metabolism; Carbon compound 
catabolism; Fatty acid and 
phospholipid metabolism 
bglX PA1726 0.58 Carbon compound catabolism 
pvdE PA2397 0.64 
Adaptation, protection; Membrane 
proteins; Transport of small molecules 
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CHAPTER 3 
BIOFILM FORMATION OF Pseudomonas aeruginosa PAO1 ON PDMS 
SURFACE CONTAINING (Z)-4-BROMO-5-(BROMOMETHYLENE)-3-
METHYLFURAN-2(5H)-ONE 
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3.1 Abstract 
Biofilms are highly-structured microbial communities attached to surfaces and enclosed in a 
matrix of extracellular polymeric substance (EPS). Bacteria in biofilms are up to 1,000 times 
more resistant to antimicrobial agents than planktonic cells. Due to high-level antibiotic 
resistance, biofilms cause chronic infections and failure of implanted medical devices. 
Previously, (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-25(H)-one (BF8) has been shown 
to inhibit quorum sensing and biofilm formation of P. aeruginosa. Here we engineered 
polydimethylsiloxane (PDMS) surfaces by including BF8 during polymerization to inhibit P. 
aeruginosa PAO1 biofilm formation. Our results showed that biofilm formation and biofilm-
associated persister cells can be significantly reduced on the PDMS surfaces containing BF8 
compared to the regular PDMS surfaces.  
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3.2 Introduction 
Bacteria are well known to attach to biotic and abiotic surfaces and form complex multicellular 
communities known as biofilms [1]. According to the National Institute of Health, biofilms are 
responsible for more than 60% of all bacterial infections [2, 3]. Bacteria in biofilms are more 
resistant to antimicrobial agents and host immune defenses, which can be attributed to the barrier 
of the extracellular matrix, the physiological state of biofilm cells, and the presence of 
subpopulations with high level drug tolerance known as persister cells [4].  
P. aeruginosa is the main cause of lung infections in cystic fibrosis patients and is a well-
recognized model organism for biofilm study [1, 5]. The development of P. aeruginosa biofilms 
occurs in a dynamic process including initial attachment, irreversible attachment, maturation and 
dispersion [1]. In P. aeruginosa, three exopolysaccharides, Psl, Pel, and alginate, have been 
characterized for their roles in formation, structure maintenance and antibiotic resistance of 
biofilms [5-7].      
Recent studies have indicated that quorum sensing (QS) systems play a major role in biofilm 
formation of different pathogens such as P. aeruginosa, Burkholderia cepacia, and 
Streptococcus intermedius [8-11]. Thus, interfering with bacterial QS systems may be a promising 
strategy to treat chronic infections caused by biofilms. Halogenated furanones produced by the 
marine red alga Delisea pulchra were the first example of natural QS inhibitors. These natural 
furanones have similar structures to acylated homoserine lactones (AHLs) and can disrupt QS by 
completing with AHLs for binding to the cognate AHL receptors [12, 13]. In order to enhance the 
QS inhibitory activities, a number of halogenated furanones have been synthesized and studied 
for the inhibition of biofilm formation by several bacterial species, such as P. aeruginosa, 
   71 
 
Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Staphylococcus epidermidis [14-18]. 
For instance, Hentzer et al. [14] developed a novel synthetic furanone compound named furanone 
56 [19], which could penetrate the P. aeruginosa biofilm matrix and interfere with AHL-mediated 
QS systems. In addition, this furanone can inhibit the production of QS-regulated virulence 
factors and biofilm development [14]. 
Thus, furanones have the potential to be used for antibacterial coatings for the prevention of 
bacterial adhesion and biofilm formation [20, 21]. Bajeva et al. [22] reported the production of S. 
epidermidis biofilms were significantly inhibited on the polymer biomaterials (for example, 
polyethylene, poly(vinyl chloride), and polyether polyurethane) with physically absorbed 
furanone (3-(1’-bromohexyl)-5-dibromomethylene-2(5H)-furanone). Meanwhile, in a separate 
study by Hume et al. [23], this furanone was covalently linked to polystyrene disks and catheters 
using two different strategies. Polystyrene-furanone disks were made through the co-
polymerization of styrene and furanone compound. For furanone-coated catheters, the catheter 
surface was coated with a plasma polymer layer and then modified with poly(acrylic acid) and 
finally grafted by furanone compound [21, 23]. Polystyrene-furanone disks and furanone-coated 
catheters showed an 89% and 78% reduction in S. epidermidis biofilm formation, respectively, 
compared to control disks and catheters [23]. In addition, some furanone-coated catheters were 
implanted into a sheep model and were capable of controlling in vivo infection for up to 65 days 
[23]. In another study, E. coli biofilms were inhibited on the polyvinyl chloride material coated 
with one brominated furanone (3,4-dibromo-5,5-dimethoxypheny-2(5H)-furanone) [24]. 
Recently, Han et al. [25] reported that (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-25(H)-
one (BF8) can inhibit E. coli biofilm formation. Subsequently, Pan et al. reported that BF8 is 
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capable of reducing the number of persister cells in established biofilms of P. aeruginosa PAO1 
[15], PDO300 [16], and E. coli [26]. In addition, BF8 appeared to be safe to the normal 3T3-L1 
preadipocytes and HS-5 bone marrow stromal cells in vitro and did not show obvious 
cytotoxicity to mice in vivo [26].   
In the present study, we investigated the effects of polydimethylsiloxane (PDMS) surfaces with 
BF8 on P. aeruginosa PAO1 biofilm formation and biofilm-associated persistence. Our results 
showed that biofilm formation and biofilm-associated persister cells were significantly reduced 
on the PDMS surfaces containing BF8 compared to the untreated PDMS surfaces.  
3.3 Materials and methods 
3.3.1 Preparation of PDMS surfaces with and without BF8 
PDMS surfaces were prepared using a SYLGARD184 silicone elastomer kit (Dow Corning Co., 
Midland, MI, USA). As shown in Figure 3-1, the compound BF8 was synthesized as reported 
previously [25]. Synthetic BF8 was dissolved in ethanol and then stored at -4ºC until use. BF8 
solution was added before making the PDMS surfaces. The control PDMS surface was added 
with 300 μl of ethanol to eliminate any solvent effect.  
 
Figure 3-1. Chemical structure of BF8. 
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3.3.2 Bacterial strain and growth media 
P. aeruginosa PAO1 were grown in Luria-Bertani (LB) medium containing 10 g/L NaCl, 10 g/L 
tryptone, and 5 g/L yeast extract, and cultured with shaking (200 rpm) at 37ºC for 18 h.  
3.3.3 Effects of PDMS surfaces containing BF8 on PAO1 biofilm formation and biofilm-
associated persistence 
Overnight culture of P. aeruginosa PAO1 was used to inoculate subcultures in LB medium to an 
optical density at 600 nm (OD600) of 0.05 in petri dishes containing 1 cm × 0.6 cm PDMS 
surfaces. Petri dishes were incubated at 37 ºC for certain time of points without shaking. PDMS 
surfaces without BF8 were used as control. One mL of medium with dispersed cells was washed 
three times with 0.85% NaCl solution and then plated on LB agar plates to determine the number 
of CFU of dispersed population. Meanwhile, 1 mL of medium with detached cells was treated 
with 200 μg/mL ciprofloxacin for 3.5 h at 37ºC for persister isolation. Then each sample was 
washed three times with 0.85% NaCl solution and plated on LB agar plates to determine CFU of 
surviving persister cells. After certain period of incubation, PDMS surfaces were washed three 
times by 0.85% NaCl solution. Then each surface was transferred to one 15mL conical tube 
containing 2mL 0.85% NaCl solution. The biofilm cells were collected by vortexing the surfaces 
for 1 min and sonicating for 1 min. The drop plate method as described previously [27] was used 
to determine CFU of collected biofilm cells. To determine the biofilm-associated persisters, the 
remaining portion of each sample was treated with 200 μg/mL ciprofloxacin for 3.5 h at 37ºC. 
After the treatment, the persister cells were washed three times with 0.85% NaCl solution. This 
experiment was performed in replicate. 
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3.3.4 Fluorescence microscopy  
To observe the biofilms formed on PDMS surfaces, the dye of acridine orange was used to stain 
P. aeruginosa PAO1 biofilms. This dye would emit green fluorescence when bound to double-
stranded DNA and red fluorescence when bound to single-stranded DNA or RNA. After 
incubation, the PDMS surfaces with PAO1 biofilm cells were gently washed three times with 
0.85% NaCl solution. Then the biofilms were stained with 0.5 mg/ml acridine orange for 2 min 
in the dark. An Axio Imager M1 fluorescence microscope (Carl Zeiss Inc., Berlin, Germany) was 
used to visualize the biofilms. The biomass of biofilm cells was calculated using COMSTAT 
software [28]. 
3.3.5 Statistical analysis 
Statistical analysis was conducted using SAS 9.1.3 Windows version (SAS, Cary, NC, USA) to 
compare the difference between the control and treatment samples. The notes of *, **, and *** 
indicate that the p-value is <0.05, <0.01, and <0.001, respectively. 
3.4 Results 
It has been reported that BF8, when added in the growth medium, can inhibit biofilm formation 
of P. aeruginosa PAO1 [15]. In the present study, we tested if the PDMS surfaces containing BF8 
could affect P. aeruginosa PAO1 biofilm formation. As shown in Figure 3-2, at the time point of 
5 h, the PDMS surfaces with 1800 μg/mL BF8 reduced the biofilm formation by 37.7% ± 4.3% 
(one-way ANOVA, p < 0.0001) and biofilm-associated persister cells by 67.2% ± 11% (one-way 
ANOVA, p < 0.0001), respectively, compared to the regular PDMS surfaces. The inhibition of 
biofilms and biofilm-associated persister cells on the PDMS surfaces with BF8 was stronger 
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after 18 h incubation. For instance, as shown in Figure 3-3, the total number of biofilm cells and 
biofilm-associated persisters were reduced by 83.8% ± 1.1% (one-way ANOVA, p < 0.0001) and 
88.3% ± 4.8% (one-way ANOVA, p < 0.0001) respectively, on the PDMS surfaces with 180 
μg/mL BF8. At 24 h after inoculation, the PDMS surfaces containing 1800 μg/mL BF8 reduced 
biofilm formation and biofilm-associated persisters by 98.2% ± 0.4% (one-way ANOVA, p < 
0.0001) and 98.7% ± 0.5% (one-way ANOVA, p < 0.0001), respectively, compared to the BF8-
free PDMS surfaces (Figure 3-4). 
Figure 3-2. Effects of PDMS surfaces containing BF8 on P. aeruginosa PAO1 biofilm formation 
for 5 h. Different concentration of BF8-ethanol solution was added before making the PDMS 
surfaces. The control PDMS surface was added with 300 μl of ethanol to eliminate any solvent 
effect. 
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Figure 3-3. Effects of PDMS surfaces containing BF8 on P. aeruginosa PAO1 biofilm formation 
for 18 h.  
 
Figure 3-4. Effects of PDMS surfaces with BF8 on P. aeruginosa PAO1 biofilm formation for 
24 h.  
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
1.00E+11
1.00E+12
1.00E+13
1.00E+14
1.00E+15
1.00E+16
1.00E+17
0 180 360 1800
Dispersed biofilm cells
Persisters in the dispersed population
Biofilm cells remained attached
Persisters remained in biofilms
Concentration of BF8 (μg/mL)
C
el
l 
n
u
m
b
er
/c
m
2
***
***
***
***
***
***
1.00E+02
1.00E+04
1.00E+06
1.00E+08
1.00E+10
1.00E+12
1.00E+14
1.00E+16
1.00E+18
1.00E+20
0 180 360 1800
Dispersed biofilm cells
Persisters in the dispersed population
Biofilm cells remained attached
Persisters remained in biofilms
Concentration of BF8 (μg/mL)
C
el
l 
n
u
m
b
er
/c
m
2
***
***
******
***
***
   77 
 
However, the level of biofilm inhibition decreased after 48 h. For example, the number of 
biofilm cells was reduced by only 50% ± 3.2% on the PDMS surface with 1800 μg/mL BF8 
(one-way ANOVA, p < 0.0001) (Figure 3-5). For 72 h biofilms, we didn’t observe the significant 
inhibition of biofilms on the PDMS surfaces containing 180 μg/mL BF8 (Figure 3-6). 
 
Figure 3-5. Effects of PDMS surfaces with BF8 on P. aeruginosa PAO1 biofilm formation for 
48 h.  
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Figure 3-6. Effects of PDMS surfaces with BF8 on P. aeruginosa PAO1 biofilm formation for 
72 h.  
 
Figure 3-7 shows the representative images of biofilms formed on the PDMS surfaces with and 
without BF8. Based on the microscopic images of biofilms, the biomass of biofilms on the 
PDMS surfaces with and without BF8 at different time points was calculated by the COMSTAT 
software (Figure 3-8). These data are consistent with the above CFU results.  
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For 5 h biofilms: 
 
Control:                                                              180 μg/ml BF8: 
            
 
360 μg/ml BF8:                                                  1800 μg/ml BF8: 
           
 
 
For 18 h biofilms: 
 
Control:                                                              180 μg/ml BF8: 
               
 
360 μg/ml BF8:                                                  1800 μg/ml BF8: 
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For 24 h biofilms: 
 
Control:                                                                180 μg/ml BF8: 
                            
 
360 μg/ml BF8:                                                   1800 μg/ml BF8: 
           
 
For 48 h biofilms: 
 
Control:                                                               180 μg/ml BF8: 
                               
 
360 μg/ml BF8:                                                   1800 μg/ml BF8: 
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For 96 h biofilms: 
 
Control:                                                                180 μg/ml BF8: 
                                
 
360 μg/ml BF8:                                                     1800 μg/ml BF8: 
              
 
Figure 3-7. Representative microscopic images of P. aeruginosa PAO1 biofilm cells on PDMS 
surfaces with and without BF8. The dye of acridine orange was used to stain P. aeruginosa 
PAO1 biofilms. 
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Figure 3-8. Relative biomass of biofilm cells on PDMS surfaces with and without BF8. The 
biomass of biofilms on the PDMS surfaces with and without BF8 was calculated by the 
COMSTAT software. The biomass of untreated controls at different time points were normalized 
to 100%.  
 
The number of dispersed biofilm cells and persister cells in the dispersed population didn’t 
change on the PDMS surfaces with different concentrations of BF8 at the different time points. 
This suggests that BF8 did not diffuse out of PDMS significantly. 
3.5 Discussion 
In this chapter, PDMS surfaces containing BF8 were prepared and compared with regular PDMS 
for P. aeruginosa PAO1 biofilm formation. Our results revealed that P. aeruginosa PAO1 
biofilm formation and biofilm-associated persisters were significantly reduced on the PDMS 
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surfaces containing BF8 compared to the PDMS surface without BF8 within 48 h. After 
inoculation for more than 48 h, however, the difference decreased.  
One previous study showed that a conjugated exocyclic vinyl bromide of BF8 is the key element 
for the inhibition of E. coli biofilm formation [25]. Pan et al. [15] reported that P. aeruginosa PAO1 
biofilms and biofilm-associated persisters were significantly inhibited by adding 60 μg/ml BF8 
as free molecules in the growth medium at inoculation. It should be noted that direct covalent 
immobilization of BF8 to a surface may attenuate its inhibition activity of biofilm formation [25]. 
By adding BF8 in the PDMS directly, we obtained significant biofilm inhibition. However, since 
most of BF8 molecules are embedded in the PDMS, it may be more efficient to combine this 
with surface coating strategies. 
In summary, the results from this study further support that bacterial cell-to-cell signaling is a 
possible target for controlling biofilm formation and persistence. Future studies with optimized 
material design and in vivo experiments will help develop better biomaterials. Additionally, 
studies on the genetic mechanism will provide a better understanding of the activities of BF8 and 
better control of biofilm-associated infections caused by P. aeruginosa.   
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APPENDIX 
Experimental protocols 
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Protocol 1 
PAO1 Persister RNA Isolation 
Harvesting Cells 
1. Grow 60 mL overnight culture of PAO1 for 18 hours. 
      2. Wash the cells twice by 0.85% NaCl solution at 8000 rpm for 10 min. 
      3. Add 200 μg/mL Cip and incubate for 3.5 hours to get persisters. 
4. Wash persisters thrice by 0.85% NaCl solution at 8000 rpm and 4ºC for 10 min. 
5. Dilute the persister culture 5 times by 0.85% NaCl solution and divide the diluted culture into 
8 falcon tubes. Each falcon tube contains 37.5 mL diluted persisters. (4 tubes for control and 4 
tubes for treatment) 
6. Treat the diluted persister culture with the specific condition of interest.  
7. During this time, pre cool all the tubes and centrifuges. 
8. Centrifuge the persister culture at 10,000 rpm and 2ºC for 2 min and decant supernatant. 
9. Flash-freeze in dry-ice, store at -80oC until use. 
Kit: RNeasy Mini Kit (50)            Source: Qiagen        Cat log. Number: 74104 
RNA Isolation 
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Preparation: 
1. Add 200uL Zirconia/Silica beads to bead beater tube & cool on ice 
2. RLT Buffer: 10 μL βME per 1 mL RLT (2 mL/sample) 
3. RPE Buffer: 8 mL EtOH per 2 mL RPE (4 mL/sample) 
4. DNase Mix: 45 μL DNase I stock per 315 μL RDD Buffer (360μL/2 samples) 
Procedure: 
1. Add 450 uL RLT buffer to all the 8 tubes with pellets. Vortex them. Combine 2 tubes of 
control and 2 tubes of treatment. In total there will be 4 tubes with 900 uL RLT mixed with cells: 
2 for control and 2 for treatment. 
2. Transfer 900 μL of RLT with cells in bead beater tubes with zirconia/silica beads.  
3. Beat 60s (set timer at 6) at speed 48 (~5000 rpm), although PAO1 is Gram negative. 
Centrifuge 15s at 13000rpm and 4ºC. 
(All centrifuge steps at these settings unless noted) 
4. Collect supernatant and add 445 μL EtOH. 
5. Load 700 μL sample onto RNeasy column (Qiagen), and then centrifuge. 
6. Add 350 μL RW1 and centrifuge. Then repeat once. 
7. Add 180 μL DNase I incubation mix directly onto membrane. 
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8. Incubate at RT for 45 min.  
9. Add 350 μL RW1 and centrifuge. Then repeat once. 
10. Add 500 μL RPE and centrifuge. Then repeat twice. 
11. Add 500 μL RPE and centrifuge for 2 min. 
12. Replace collection tube and centrifuge for 1 min. 
13. Place column in 1.5 collection tube. 
14. Add 40 μL RNase-free water and centrifuge for 1 min. Then repeat once. 
Clean-up 
1. Add 900 μL RLT Buffer to primary RNA product. 
2. Add 445 μL EtOH. 
3. Load 700 μL sample onto RNeasy column (Qiagen), and then centrifuge. 
4. Add 350 μL RW1 and centrifuge. Then repeat once. 
5. Add 180 μL DNase I incubation mix directly onto membrane. 
6. Incubate at RT for 30 min.  
7. Add 350 μL RW1 and centrifuge. Then repeat once. 
8. Add 500 μL RPE and centrifuge. Then repeat twice. 
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9. Add 500 μL RPE and centrifuge for 2 min. 
10. Replace collection tube, centrifuge for 1 min. 
11. Place column in 1.5 collection tube 
12. Add 40 μL RNase-free water and centrifuge for 1 min. Then repeat once. 
Save flow-through! 
Quantification 
1. Measure OD at 260 nm and 280 nm (using TE as the background) 
o Yield: OD260 of 1.0 = 40 μg/mL 
o Calculation: RNA concentration = 40 μg/mL × OD260 × dilution factor 
o Ratio:  OD260/OD280 should be >2.0 
2. Run 1.4% agarose gel (0.42g agarose, 30 mL 1xTAE) 
o Should have two clear bands (23S at 3.1kb, 16S at 1.5kb) 
o Smearing patterns at low molecular range indicate RNase contamination 
 
Protocol 2 
qPCR Analysis 
cDNA Synthesis 
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1. Thaw the components in the iScript cDNA synthesis kit and then mix them as shown below. 
Components Volume per Reaction 
5x iScript reaction mix 4 μl 
iScript reverst transcriptase 1 μl 
Nuclease-free water 12.5 μl 
RNA template 2.5 μl 
Total volume 20 μl 
2. Incubate the above reaction mix in the thermo cycler and run the program shown as: 5 minutes 
at 25ºC, 30 minutes at 42ºC, 5 minutes at 85ºC, hold at 4ºC.  
Reaction mix preparation and thermal cycling 
1. Thaw cDNA samples and dilute them to the concentration of 40ng/μl.  
2. Thaw forward and reverse primers, iTaq Universal SYBR Green supermix and nuclease-free 
water. Then mix them as shown below: 
Components 
Volume per 20 μl 
Reaction 
iTaq Universal SYBR Green supermix 10 μl 
Primer mix (forward and reverse) 1 μl 
Nuclease-free water 4 μl 
cDNA  5 μl 
Total volume 20 μl 
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3. Add the reaction mix into the wells of a qPCR plate. Spin the qPCR plate by using the plate 
centrifuge at 3000rpm for 5min. 
4. Set the program of qPCR instrument and then run the PCR. 
Protocol 3  
Monocyte cell culture (THP-1) 
Subculturing procedures for frozen cells 
1. Add 5 ml complete culture medium (RPMI 1640 + 5% FBS + 1% Pen/Strep) into a 25 cm2 
tissue culture flask. Put the flask into the incubator for at least 15 minutes to make sure that the 
pH value of the medium is in the range of 7.0-7.6. 
2. Thaw the vial of macrophage cells in the water bath under 37℃ for about 2 minutes.  
3. Add 9.0mL complete culture medium into a 15ml centrifuge tube.  
4. Remove the vial from the water bath immediately after the vial contents are thawed. Withdraw 
the vial contents into the above 15ml centrifuge tube.  
5. Centrifuge them at approximately 125xg for 5 to 7 minutes. Remove the supernatant from the 
centrifuge tube. 
6. Take out the 25cm2 tissue culture flask containing complete culture medium from the 
incubator. Add certain medium into the above centrifuge tube. Withdraw the cells into the 25cm2 
tissue culture flask. 
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7. Use the microscope to check macrophage cells. Then put the 25cm2 tissue culture flask into 
the incubator. 
Subculturing procedures for the suspension cells 
1. After put 25cm2 tissue culture flask containing macrophage cells into the incubator, use the 
microscope to check macrophage cells.  
2. Add 4ml complete culture medium into a 25cm2 tissue culture flask. Put the flask into the 
incubator for at least 15 minutes to make sure that the pH value of the medium is in the range of 
7.0-7.6. 
3. When the macrophage cell concentration reaches 8×105 cells/ml, use the pipette aid to 
withdraw 1ml cells suspension into the above 25cm2 tissue culture flask containing 4.0ml fresh 
medium (RPMI 1640 + 5% FBS + 1% Pen/Strep). 
4. Put the flask into the 37℃ incubator.  
Freezing cells grown in suspension culture 
1. Transfer cell solution to a 15ml conical tube and then centrifuge it at approximately 125 xg for 
5 min. 
2. Remove supernatant and resuspend pellet in the above medium (RPMI 1640 + 5% FBS + 1% 
Pen/Strep + 5% DMSO) at a density of 106 to 107 cells/ml. 
3. Transfer 1ml aliquots of cell suspension into cryovials and then put cryovials into the 
cryopreservation container. 
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4. Put the cryopreservation container in the -80 freezer for overnight and then put the cryovials 
into the liquid nitrogen. 
Phagocytosis assay 
Day 1  
1. Culture the THP-1 cells as mentioned above and transfer 5 ml of THP-1 cell culture into a new 
culture dish.  
2. Add 100 ng/ml PMA into the culture of THP-1 cells for differentiation and put the culture dish 
into the incubator (in Room 437) for 2 days.  
Day 3 
1.  After 2 days, add 5 ml complete culture medium (RPMI 1640 + 5% FBS) into a tissue culture 
dish. Put the culture dish into the incubator for at least 15 minutes to make sure that the pH value 
of the medium is in the range of 7.0-7.6.  
2. Take out the culture dish containing differentiated THP-1 cells from the incubator. Then 
replace the old medium in the culture dish with the preheated culture medium from tissue culture 
flask.   
3. Add 100 ng/ml E.coli LPS into the culture dish containing differentiated THP-1 cells for 1 day. 
4. Make the overnight culture of E. coli RP 437 (or acrA mutant, acrB mutant).  
 Day 4 
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1. After 1 day, make the 0.1mg/ml FITC dye (dissolved in 0.1M NaHCO3) solution before use. 
Then stain the E. coli RP 437 cells using 0.1mg/ml FITC dye for 1 hr at room temperature and 
then washed bacteria once using 1×PBS. 
2. Add the FITC-labeled bacteria into the culture dish containing THP-1 cells for 2 hrs. 
3. After 2h, add the 50 μg/ml ethidium bromide and then observe using inverted microscope. 
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